,geneProtein_label,therapy_label,disease_label,drug_label,NDCCode_label,combinationDrug_label,negGeProDr_label,firstLine,acceleratedApproval,acceleratedApprovalRate,metastatic
0,PD-L1,Atezolizumab,Urothelial carcinoma,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86",,,,Yes,Yes,Yes
1,*,Atezolizumab,Urothelial carcinoma,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86",,,,Yes,Yes,
2,*,Atezolizumab,Small cell lung cancer,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86","carboplatin, etoposide",,Yes,,,
3,BRAF,Atezolizumab,Melanoma,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86",vemurafenib,,,,,Yes
4,PD-L1,Atezolizumab,Non-small cell lung cancer,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86",,"EGFR, ALK genomic",Yes,,,Yes
5,EGFR,Atezolizumab,Non-small cell lung cancer,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86",,"EGFR, ALK genomic",Yes,,,Yes
6,ALK genomic,Atezolizumab,Non-small cell lung cancer,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86",,"EGFR, ALK genomic",Yes,,,Yes
7,EGFR,Atezolizumab,Non-small cell lung cancer,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86","paclitaxel, bevacizumab, carboplatin","EGFR, ALK genomic",,,,
8,ALK genomic,Atezolizumab,Non-small cell lung cancer,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86","paclitaxel, bevacizumab, carboplatin","EGFR, ALK genomic",,,,
9,EGFR,Atezolizumab,Non-small cell lung cancer,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86","paclitaxel, carboplatin","EGFR, ALK genomic",,,,
10,ALK genomic,Atezolizumab,Non-small cell lung cancer,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86","paclitaxel, carboplatin","EGFR, ALK genomic",,,,
11,EGFR,Atezolizumab,Non-small cell lung cancer,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86",,,,,,
12,ALK genomic,Atezolizumab,Non-small cell lung cancer,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86",,,,,,
13,*,Atezolizumab,Hepatocellular carcinoma,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86",bevacizumab,,,,,Yes
14,PD-L1,Atezolizumab,Breast cancer,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86",paclitaxel,,,Yes,,
15,*,Atezolizumab,Breast cancer,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86",,,,Yes,,
16,*,Atezolizumab,Breast cancer,"TECENTRIQ- atezolizumab injection, solution","50242-917-01, 50242-917-86, 50242-918-01, 50242-918-86",paclitaxel,paclitaxel,,Yes,,
17,*,Nivolumab,Malignant pleural mesothelioma,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",ipilimumab,,Yes,,,Yes
18,SCCHN,Nivolumab,Squamous cell carcinoma of the head and neck,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",,,,,,Yes
19,*,Nivolumab,Urothelial carcinoma,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",,,,Yes,Yes,Yes
20,*,Nivolumab,Urothelial carcinoma,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",,,,Yes,Yes,
21,*,Nivolumab,Renal cell carcinoma,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",ipilimumab,,,,,
22,*,Nivolumab,Renal cell carcinoma,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",cabozantinib,,,,,
23,*,Nivolumab,gastroesophageal junction adenocarcinoma,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",,,,,,
24,*,Nivolumab,Classic Hodgkin lymphoma,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",,,,,,
25,*,Nivolumab,Melanoma,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",ipilimumab,,,,,Yes
26,*,Nivolumab,Melanoma,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",,,,,,
27,PD-L1,Nivolumab,Non-small cell lung cancer,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",ipilimumab,"EGFR, ALK genomic",Yes,,,Yes
28,≥1,Nivolumab,Non-small cell lung cancer,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",ipilimumab,"EGFR, ALK genomic",Yes,,,Yes
29,EGFR,Nivolumab,Non-small cell lung cancer,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",ipilimumab,"EGFR, ALK genomic",Yes,,,Yes
30,ALK genomic,Nivolumab,Non-small cell lung cancer,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",ipilimumab,"EGFR, ALK genomic",Yes,,,Yes
31,EGFR,Nivolumab,Non-small cell lung cancer,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",ipilimumab,"EGFR, ALK genomic",Yes,,,
32,ALK genomic,Nivolumab,Non-small cell lung cancer,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",ipilimumab,"EGFR, ALK genomic",Yes,,,
33,EGFR,Nivolumab,Non-small cell lung cancer,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",,,,,,
34,ALK genomic,Nivolumab,Non-small cell lung cancer,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",,,,,,
35,*,Nivolumab,Hepatocellular carcinoma,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",ipilimumab,,,Yes,Yes,
36,*,Nivolumab,Hepatocellular carcinoma,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",,,,Yes,Yes,
37,*,Nivolumab,esophageal cancer,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",,,,,,
38,*,Nivolumab,Gastric (stomach) cancer,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",,,,,,
39,MSI-H,Nivolumab,Colorectal cancer,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",ipilimumab,,,Yes,Yes,Yes
40,*,Nivolumab,Colorectal cancer,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",,,,Yes,Yes,
41,*,Nivolumab,Esophageal cancer or gastroesophageal junction adenocarcinoma,OPDIVO- nivolumab injection,"0003-3734-13, 0003-3772-11, 0003-3774-12",,,,,,
42,*,Avelumab,Renal cell carcinoma,"BAVENCIO- avelumab injection, solution, concentrate",44087-3535-1,axitinib,,Yes,,,
43,*,Avelumab,Merkel cell carcinoma,"BAVENCIO- avelumab injection, solution, concentrate",44087-3535-1,,,,Yes,Yes,Yes
44,*,Avelumab,Merkel cell carcinoma,"BAVENCIO- avelumab injection, solution, concentrate",44087-3535-1,,,,Yes,Yes,
45,*,Avelumab,Urothelial carcinoma,"BAVENCIO- avelumab injection, solution, concentrate",44087-3535-1,,,,,,Yes
46,*,Pembrolizumab,Squamous cell carcinoma of the head and neck,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,,,
47,PD-L1,Pembrolizumab,Urothelial carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,Yes
48,CPS ≥10,Pembrolizumab,Urothelial carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,Yes
49,*,Pembrolizumab,Urothelial carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
50,*,Pembrolizumab,Urothelial carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,Yes
51,*,Pembrolizumab, gastroesophageal junction cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,,,
52,*,Pembrolizumab,gastroesophageal junction adenocarcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,,,
53,*,Pembrolizumab,Merkel cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,Yes
54,*,Pembrolizumab,Merkel cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
55,*,Pembrolizumab,Melanoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,,,Yes
56,*,Pembrolizumab,Melanoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,,,
57,*,Pembrolizumab,Hepatocellular carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
58,PD-L1,Pembrolizumab,Cervical cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,Yes
59,CPS ≥1,Pembrolizumab,Cervical cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,Yes
60,*,Pembrolizumab,Cervical cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
61,*,Pembrolizumab,Primary mediastinal large B-cell lymphoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,,,
62,*,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
63,EGFR,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02","pemetrexed, platinum","EGFR, ALK genomic",,Yes,Yes,
64,ALK genomic,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02","pemetrexed, platinum","EGFR, ALK genomic",,Yes,Yes,
65,*,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02","paclitaxel, carboplatin",,,Yes,Yes,
66,TPS,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,Yes,Yes,
67,EGFR,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,Yes,Yes,
68,ALK genomic,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,Yes,Yes,
69,≥1,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,Yes,Yes,
70,PD-L1,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,Yes,Yes,
71,PD-L1,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
72,TPS ≥1,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
73,TPS,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
74,EGFR,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
75,ALK genomic,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
76,*,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02","FU, fluorouracil, platinum",,,Yes,Yes,
77,≥1,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
78,CPS ≥10,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
79,MSI-H,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
80,*,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,MSI-H,,Yes,Yes,
81,*,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",trastuzumab,,,Yes,Yes,
82,CPS ≥1,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
83,*,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",axitinib,,,Yes,Yes,
84,MSI-H,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",lenvatinib,MSI-H,,Yes,Yes,
85,mut/Mb,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
86,≥10 mutations/megabase,Pembrolizumab,Breast cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
87,*,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
88,EGFR,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02","pemetrexed, platinum","EGFR, ALK genomic",,Yes,Yes,
89,ALK genomic,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02","pemetrexed, platinum","EGFR, ALK genomic",,Yes,Yes,
90,*,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02","paclitaxel, carboplatin",,,Yes,Yes,
91,TPS,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,Yes,Yes,
92,EGFR,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,Yes,Yes,
93,ALK genomic,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,Yes,Yes,
94,≥1,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,Yes,Yes,
95,PD-L1,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,Yes,Yes,
96,PD-L1,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
97,TPS ≥1,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
98,TPS,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
99,EGFR,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
100,ALK genomic,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
101,*,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02","FU, fluorouracil, platinum",,,Yes,Yes,
102,≥1,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
103,CPS ≥10,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
104,MSI-H,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
105,*,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,MSI-H,,Yes,Yes,
106,*,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",trastuzumab,,,Yes,Yes,
107,CPS ≥1,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
108,*,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",axitinib,,,Yes,Yes,
109,MSI-H,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",lenvatinib,MSI-H,,Yes,Yes,
110,mut/Mb,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
111,≥10 mutations/megabase,Pembrolizumab,Solid tumors,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
112,*,Pembrolizumab,Gastric (stomach) cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,,,
113,MSI-H,Pembrolizumab,Endometrial carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",lenvatinib,MSI-H,,Yes,Yes,
114,*,Pembrolizumab,Endometrial carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
115,*,Pembrolizumab,Classic Hodgkin lymphoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,,,
116,EGFR,Pembrolizumab,Non-small cell lung cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02","pemetrexed, platinum","EGFR, ALK genomic",Yes,,,
117,ALK genomic,Pembrolizumab,Non-small cell lung cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02","pemetrexed, platinum","EGFR, ALK genomic",Yes,,,
118,*,Pembrolizumab,Non-small cell lung cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02","paclitaxel, carboplatin",,,,,
119,TPS,Pembrolizumab,Non-small cell lung cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,,,
120,EGFR,Pembrolizumab,Non-small cell lung cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,,,
121,ALK genomic,Pembrolizumab,Non-small cell lung cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,,,
122,≥1,Pembrolizumab,Non-small cell lung cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,,,
123,PD-L1,Pembrolizumab,Non-small cell lung cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,,,
124,PD-L1,Pembrolizumab,Non-small cell lung cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,,,
125,TPS ≥1,Pembrolizumab,Non-small cell lung cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,,,
126,TPS,Pembrolizumab,Non-small cell lung cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,,,
127,EGFR,Pembrolizumab,Non-small cell lung cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,,,
128,ALK genomic,Pembrolizumab,Non-small cell lung cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,,,
129,PD-L1,Pembrolizumab,Esophageal,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,,,Yes
130,CPS ≥10,Pembrolizumab,Esophageal,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,,,Yes
131,*,Pembrolizumab,Renal cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",axitinib,,Yes,,,
132,*,Pembrolizumab,Microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) cancer,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,,,
133,*,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
134,EGFR,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02","pemetrexed, platinum","EGFR, ALK genomic",,Yes,Yes,
135,ALK genomic,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02","pemetrexed, platinum","EGFR, ALK genomic",,Yes,Yes,
136,*,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02","paclitaxel, carboplatin",,,Yes,Yes,
137,TPS,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,Yes,Yes,
138,EGFR,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,Yes,Yes,
139,ALK genomic,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,Yes,Yes,
140,≥1,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,Yes,Yes,
141,PD-L1,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,"EGFR, ALK genomic",,Yes,Yes,
142,PD-L1,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
143,TPS ≥1,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
144,TPS,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
145,EGFR,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
146,ALK genomic,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
147,*,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02","FU, fluorouracil, platinum",,,Yes,Yes,
148,≥1,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
149,CPS ≥10,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
150,MSI-H,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
151,*,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,MSI-H,,Yes,Yes,
152,*,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",trastuzumab,,,Yes,Yes,
153,CPS ≥1,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
154,*,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",axitinib,,,Yes,Yes,
155,MSI-H,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",lenvatinib,MSI-H,,Yes,Yes,
156,mut/Mb,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
157,≥10 mutations/megabase,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,
158,*,Pembrolizumab,Cutaneous squamous cell carcinoma,"KEYTRUDA- pembrolizumab injection, powder, lyophilized, for solution","0006-3026-01, 0006-3026-02, 0006-3026-04, 0006-3029-01, 0006-3029-02",,,,Yes,Yes,Yes
159,FGFR3,Erdafitinib,Urothelial carcinoma,"BALVERSA- erdafitinib tablet, film coated","59676-030-56, 59676-030-84, 59676-040-28, 59676-040-56, 59676-050-28",,,,Yes,Yes,Yes
160,FGFR2,Erdafitinib,Urothelial carcinoma,"BALVERSA- erdafitinib tablet, film coated","59676-030-56, 59676-030-84, 59676-040-28, 59676-040-56, 59676-050-28",,,,Yes,Yes,Yes
161,FGFR2 genetic,Erdafitinib,Urothelial carcinoma,"BALVERSA- erdafitinib tablet, film coated","59676-030-56, 59676-030-84, 59676-040-28, 59676-040-56, 59676-050-28",,,,Yes,Yes,Yes
162,*,Erdafitinib,Urothelial carcinoma,"BALVERSA- erdafitinib tablet, film coated","59676-030-56, 59676-030-84, 59676-040-28, 59676-040-56, 59676-050-28",,,,Yes,Yes,
163,death-ligand 1,Enfortumab Vedotin-ejfv,Urothelial cancer,"PADCEV EJFV- enfortumab vedotin injection, powder, lyophilized, for solution","51144-020-01, 51144-030-01",,,,Yes,Yes,Yes
164,neoadjuvant/adjuvant,Enfortumab Vedotin-ejfv,Urothelial cancer,"PADCEV EJFV- enfortumab vedotin injection, powder, lyophilized, for solution","51144-020-01, 51144-030-01",,,,Yes,Yes,Yes
165,PD-L1,Enfortumab Vedotin-ejfv,Urothelial cancer,"PADCEV EJFV- enfortumab vedotin injection, powder, lyophilized, for solution","51144-020-01, 51144-030-01",,,,Yes,Yes,Yes
166,PD-1,Enfortumab Vedotin-ejfv,Urothelial cancer,"PADCEV EJFV- enfortumab vedotin injection, powder, lyophilized, for solution","51144-020-01, 51144-030-01",,,,Yes,Yes,Yes
167,*,Enfortumab Vedotin-ejfv,Urothelial cancer,"PADCEV EJFV- enfortumab vedotin injection, powder, lyophilized, for solution","51144-020-01, 51144-030-01",,,,Yes,Yes,
168,*,Sacituzumab Govitecan-hziy,Breast cancer,"TRODELVY- sacituzumab govitecan powder, for solution",55135-132-01,,,,,,
169,PD-L1,Sacituzumab Govitecan-hziy,Urothelial cancer,"TRODELVY- sacituzumab govitecan powder, for solution",55135-132-01,,,,Yes,Yes,Yes
170,PD-1,Sacituzumab Govitecan-hziy,Urothelial cancer,"TRODELVY- sacituzumab govitecan powder, for solution",55135-132-01,,,,Yes,Yes,Yes
171,death-ligand 1,Sacituzumab Govitecan-hziy,Urothelial cancer,"TRODELVY- sacituzumab govitecan powder, for solution",55135-132-01,,,,Yes,Yes,Yes
172,*,Sacituzumab Govitecan-hziy,Urothelial cancer,"TRODELVY- sacituzumab govitecan powder, for solution",55135-132-01,,,,Yes,Yes,
173,*,Bevacizumab,primary peritoneal cancer,"AVASTIN- bevacizumab injection, solution","50242-060-01, 50242-060-10, 50242-061-01, 50242-061-10","paclitaxel, carboplatin",,,,,
174,*,Bevacizumab,primary peritoneal cancer,"AVASTIN- bevacizumab injection, solution","50242-060-01, 50242-060-10, 50242-061-01, 50242-061-10","topotecan, liposomal doxorubicin, paclitaxel",,,,,
175,*,Bevacizumab,primary peritoneal cancer,"AVASTIN- bevacizumab injection, solution","50242-060-01, 50242-060-10, 50242-061-01, 50242-061-10","paclitaxel, carboplatin, Avastin, gemcitabine",,,,,
176,*,Bevacizumab,Nonsquamous non-small cell lung cancer,"AVASTIN- bevacizumab injection, solution","50242-060-01, 50242-060-10, 50242-061-01, 50242-061-10",,,,,,
177,interferon alfa,Bevacizumab,Renal cell carcinoma,"AVASTIN- bevacizumab injection, solution","50242-060-01, 50242-060-10, 50242-061-01, 50242-061-10",,,,,,Yes
178,*,Bevacizumab,Glioblastoma,"AVASTIN- bevacizumab injection, solution","50242-060-01, 50242-060-10, 50242-061-01, 50242-061-10",,,,,,
179,*,Bevacizumab,Ovarian epithelial,"AVASTIN- bevacizumab injection, solution","50242-060-01, 50242-060-10, 50242-061-01, 50242-061-10",,,,,,
180,*,Bevacizumab,Hepatocellular carcinoma,"AVASTIN- bevacizumab injection, solution","50242-060-01, 50242-060-10, 50242-061-01, 50242-061-10",atezolizumab,,,,,Yes
181,*,Bevacizumab,fallopian tube,"AVASTIN- bevacizumab injection, solution","50242-060-01, 50242-060-10, 50242-061-01, 50242-061-10","paclitaxel, carboplatin",,,,,
182,*,Bevacizumab,fallopian tube,"AVASTIN- bevacizumab injection, solution","50242-060-01, 50242-060-10, 50242-061-01, 50242-061-10","topotecan, liposomal doxorubicin, paclitaxel",,,,,
183,*,Bevacizumab,fallopian tube,"AVASTIN- bevacizumab injection, solution","50242-060-01, 50242-060-10, 50242-061-01, 50242-061-10","paclitaxel, carboplatin, Avastin, gemcitabine",,,,,
184,*,Bevacizumab,Colorectal cancer,"AVASTIN- bevacizumab injection, solution","50242-060-01, 50242-060-10, 50242-061-01, 50242-061-10",intravenous fluorouracil-based,,Yes,,,Yes
185,*,Bevacizumab,Colorectal cancer,"AVASTIN- bevacizumab injection, solution","50242-060-01, 50242-060-10, 50242-061-01, 50242-061-10",,,,,,
186,*,Bevacizumab,Colorectal cancer,"AVASTIN- bevacizumab injection, solution","50242-060-01, 50242-060-10, 50242-061-01, 50242-061-10",,Avastin,,,,
187,*,Bevacizumab,Cervical cancer,"AVASTIN- bevacizumab injection, solution","50242-060-01, 50242-060-10, 50242-061-01, 50242-061-10","cisplatin, paclitaxel, topotecan",,,,,Yes
188,*,Bevacizumab,primary peritoneal cancer,"MVASI- bevacizumab-awwb injection, solution","55513-206-01, 55513-207-01",,,,,,
189,*,Bevacizumab,Nonsquamous non-small cell lung cancer,"MVASI- bevacizumab-awwb injection, solution","55513-206-01, 55513-207-01",,,,,,
190,interferon-alfa,Bevacizumab,Renal cell carcinoma,"MVASI- bevacizumab-awwb injection, solution","55513-206-01, 55513-207-01",interferon-alfa,,,,,Yes
191,*,Bevacizumab,Glioblastoma,"MVASI- bevacizumab-awwb injection, solution","55513-206-01, 55513-207-01",,,,,,
192,*,Bevacizumab,Ovarian epithelial,"MVASI- bevacizumab-awwb injection, solution","55513-206-01, 55513-207-01",,,,,,
193,*,Bevacizumab,Hepatocellular carcinoma,"MVASI- bevacizumab-awwb injection, solution","55513-206-01, 55513-207-01",,,,,,
194,*,Bevacizumab,fallopian tube,"MVASI- bevacizumab-awwb injection, solution","55513-206-01, 55513-207-01",,,,,,
195,*,Bevacizumab,Colorectal cancer,"MVASI- bevacizumab-awwb injection, solution","55513-206-01, 55513-207-01",intravenous fluorouracil-based,,,,,Yes
196,*,Bevacizumab,Colorectal cancer,"MVASI- bevacizumab-awwb injection, solution","55513-206-01, 55513-207-01",,,,,,
197,*,Bevacizumab,Cervical cancer,"MVASI- bevacizumab-awwb injection, solution","55513-206-01, 55513-207-01","cisplatin, paclitaxel, topotecan",,,,,Yes
198,*,Bevacizumab,primary peritoneal cancer,"ZIRABEV- bevacizumab-bvzr injection, solution","0069-0315-01, 0069-0342-01","paclitaxel, carboplatin",,,,,
199,*,Bevacizumab,primary peritoneal cancer,"ZIRABEV- bevacizumab-bvzr injection, solution","0069-0315-01, 0069-0342-01","topotecan, liposomal doxorubicin, paclitaxel",,,,,
200,*,Bevacizumab,primary peritoneal cancer,"ZIRABEV- bevacizumab-bvzr injection, solution","0069-0315-01, 0069-0342-01","ZIRABEV, paclitaxel, carboplatin, gemcitabine",,,,,
201,*,Bevacizumab,Nonsquamous non-small cell lung cancer,"ZIRABEV- bevacizumab-bvzr injection, solution","0069-0315-01, 0069-0342-01",,,,,,
202,interferon alfa,Bevacizumab,Renal cell carcinoma,"ZIRABEV- bevacizumab-bvzr injection, solution","0069-0315-01, 0069-0342-01",,,,,,Yes
203,*,Bevacizumab,Glioblastoma,"ZIRABEV- bevacizumab-bvzr injection, solution","0069-0315-01, 0069-0342-01",,,,,,
204,*,Bevacizumab,Ovarian epithelial,"ZIRABEV- bevacizumab-bvzr injection, solution","0069-0315-01, 0069-0342-01",,,,,,
205,*,Bevacizumab,Hepatocellular carcinoma,"ZIRABEV- bevacizumab-bvzr injection, solution","0069-0315-01, 0069-0342-01",,,,,,
206,*,Bevacizumab,fallopian tube,"ZIRABEV- bevacizumab-bvzr injection, solution","0069-0315-01, 0069-0342-01","paclitaxel, carboplatin",,,,,
207,*,Bevacizumab,fallopian tube,"ZIRABEV- bevacizumab-bvzr injection, solution","0069-0315-01, 0069-0342-01","topotecan, liposomal doxorubicin, paclitaxel",,,,,
208,*,Bevacizumab,fallopian tube,"ZIRABEV- bevacizumab-bvzr injection, solution","0069-0315-01, 0069-0342-01","ZIRABEV, paclitaxel, carboplatin, gemcitabine",,,,,
209,*,Bevacizumab,Colorectal cancer,"ZIRABEV- bevacizumab-bvzr injection, solution","0069-0315-01, 0069-0342-01",intravenous fluorouracil-based,,,,,Yes
210,*,Bevacizumab,Colorectal cancer,"ZIRABEV- bevacizumab-bvzr injection, solution","0069-0315-01, 0069-0342-01",,,,,,
211,*,Bevacizumab,Cervical cancer,"ZIRABEV- bevacizumab-bvzr injection, solution","0069-0315-01, 0069-0342-01","cisplatin, paclitaxel, topotecan",,,,,Yes
212,*,Everolimus,gastrointestinal cancer,EVEROLIMUS- everolimus tablets tablet,"51991-379-60, 51991-379-99, 51991-380-60, 51991-380-99, 51991-381-60, 51991-381-99",,,,,,
213,*,Everolimus,Renal cell carcinoma,EVEROLIMUS- everolimus tablets tablet,"51991-379-60, 51991-379-99, 51991-380-60, 51991-380-99, 51991-381-60, 51991-381-99",,,,,,
214,*,Everolimus,Pancreatic cancer,EVEROLIMUS- everolimus tablets tablet,"51991-379-60, 51991-379-99, 51991-380-60, 51991-380-99, 51991-381-60, 51991-381-99",,,,,,
215,*,Everolimus,lung cancer,EVEROLIMUS- everolimus tablets tablet,"51991-379-60, 51991-379-99, 51991-380-60, 51991-380-99, 51991-381-60, 51991-381-99",,,,,,
216,*,Everolimus,Breast cancer,EVEROLIMUS- everolimus tablets tablet,"51991-379-60, 51991-379-99, 51991-380-60, 51991-380-99, 51991-381-60, 51991-381-99",,,,,,
217,*,Everolimus,Subependymal giant cell astrocytoma,EVEROLIMUS- everolimus tablets tablet,"51991-379-60, 51991-379-99, 51991-380-60, 51991-380-99, 51991-381-60, 51991-381-99",,,,,,
218,*,Everolimus,gastrointestinal cancer,EVEROLIMUS tablet,"51991-821-28, 51991-821-99, 51991-822-28, 51991-822-99, 51991-823-28, 51991-823-99, 51991-824-28, 51991-824-99",,,,,,
219,sunitinib,Everolimus,Renal cell carcinoma,EVEROLIMUS tablet,"51991-821-28, 51991-821-99, 51991-822-28, 51991-822-99, 51991-823-28, 51991-823-99, 51991-824-28, 51991-824-99",,sunitinib,,,,
220,*,Everolimus,Pancreatic cancer,EVEROLIMUS tablet,"51991-821-28, 51991-821-99, 51991-822-28, 51991-822-99, 51991-823-28, 51991-823-99, 51991-824-28, 51991-824-99",,,,,,
221,*,Everolimus,lung cancer,EVEROLIMUS tablet,"51991-821-28, 51991-821-99, 51991-822-28, 51991-822-99, 51991-823-28, 51991-823-99, 51991-824-28, 51991-824-99",,,,,,
222,*,Everolimus,Breast cancer,EVEROLIMUS tablet,"51991-821-28, 51991-821-99, 51991-822-28, 51991-822-99, 51991-823-28, 51991-823-99, 51991-824-28, 51991-824-99",,,,,,
223,*,Everolimus,Subependymal giant cell astrocytoma,EVEROLIMUS tablet,"51991-821-28, 51991-821-99, 51991-822-28, 51991-822-99, 51991-823-28, 51991-823-99, 51991-824-28, 51991-824-99",,,,,,
224,*,Everolimus,gastrointestinal cancer,EVEROLIMUS tablet,"0054-0470-21, 0054-0471-21, 0054-0472-21",,,,,,
225,*,Everolimus,Renal cell carcinoma,EVEROLIMUS tablet,"0054-0470-21, 0054-0471-21, 0054-0472-21",,,,,,
226,*,Everolimus,Pancreatic cancer,EVEROLIMUS tablet,"0054-0470-21, 0054-0471-21, 0054-0472-21",,,,,,
227,*,Everolimus,lung cancer,EVEROLIMUS tablet,"0054-0470-21, 0054-0471-21, 0054-0472-21",,,,,,
228,*,Everolimus,Breast cancer,EVEROLIMUS tablet,"0054-0470-21, 0054-0471-21, 0054-0472-21",,,,,,
229,*,Everolimus,Subependymal giant cell astrocytoma,EVEROLIMUS tablet,"0054-0470-21, 0054-0471-21, 0054-0472-21",,,,,,
230,*,Everolimus,gastrointestinal cancer,EVEROLIMUS tablet,"0054-0480-13, 0054-0480-14, 0054-0480-22, 0054-0481-13, 0054-0481-14, 0054-0481-22, 0054-0497-13, 0054-0497-14, 0054-0497-22",,,,,,
231,sunitinib,Everolimus,Renal cell carcinoma,EVEROLIMUS tablet,"0054-0480-13, 0054-0480-14, 0054-0480-22, 0054-0481-13, 0054-0481-14, 0054-0481-22, 0054-0497-13, 0054-0497-14, 0054-0497-22",,sunitinib,,,,
232,*,Everolimus,Pancreatic cancer,EVEROLIMUS tablet,"0054-0480-13, 0054-0480-14, 0054-0480-22, 0054-0481-13, 0054-0481-14, 0054-0481-22, 0054-0497-13, 0054-0497-14, 0054-0497-22",,,,,,
233,*,Everolimus,lung cancer,EVEROLIMUS tablet,"0054-0480-13, 0054-0480-14, 0054-0480-22, 0054-0481-13, 0054-0481-14, 0054-0481-22, 0054-0497-13, 0054-0497-14, 0054-0497-22",,,,,,
234,*,Everolimus,Breast cancer,EVEROLIMUS tablet,"0054-0480-13, 0054-0480-14, 0054-0480-22, 0054-0481-13, 0054-0481-14, 0054-0481-22, 0054-0497-13, 0054-0497-14, 0054-0497-22",,,,,,
235,*,Everolimus,Subependymal giant cell astrocytoma,EVEROLIMUS tablet,"0054-0480-13, 0054-0480-14, 0054-0480-22, 0054-0481-13, 0054-0481-14, 0054-0481-22, 0054-0497-13, 0054-0497-14, 0054-0497-22",,,,,,
236,*,Everolimus,gastrointestinal cancer,EVEROLIMUS tablet,"0378-3096-28, 0378-3096-32, 0378-3096-85, 0378-3097-28, 0378-3097-32, 0378-3097-85, 0378-3098-28, 0378-3098-32, 0378-3098-85",,,,,,
237,*,Everolimus,Renal cell carcinoma,EVEROLIMUS tablet,"0378-3096-28, 0378-3096-32, 0378-3096-85, 0378-3097-28, 0378-3097-32, 0378-3097-85, 0378-3098-28, 0378-3098-32, 0378-3098-85",,,,,,
238,*,Everolimus,Pancreatic cancer,EVEROLIMUS tablet,"0378-3096-28, 0378-3096-32, 0378-3096-85, 0378-3097-28, 0378-3097-32, 0378-3097-85, 0378-3098-28, 0378-3098-32, 0378-3098-85",,,,,,
239,*,Everolimus,lung cancer,EVEROLIMUS tablet,"0378-3096-28, 0378-3096-32, 0378-3096-85, 0378-3097-28, 0378-3097-32, 0378-3097-85, 0378-3098-28, 0378-3098-32, 0378-3098-85",,,,,,
240,*,Everolimus,Breast cancer,EVEROLIMUS tablet,"0378-3096-28, 0378-3096-32, 0378-3096-85, 0378-3097-28, 0378-3097-32, 0378-3097-85, 0378-3098-28, 0378-3098-32, 0378-3098-85",exemestane,letrozole,,,,
241,*,Everolimus,Subependymal giant cell astrocytoma,EVEROLIMUS tablet,"0378-3096-28, 0378-3096-32, 0378-3096-85, 0378-3097-28, 0378-3097-32, 0378-3097-85, 0378-3098-28, 0378-3098-32, 0378-3098-85",,,,,,
242,*,Everolimus,gastrointestinal cancer,EVEROLIMUS tablet,"63850-0062-2, 63850-0062-3, 63850-0063-2, 63850-0063-3, 63850-0064-2",,,,,,
243,*,Everolimus,Renal cell carcinoma,EVEROLIMUS tablet,"63850-0062-2, 63850-0062-3, 63850-0063-2, 63850-0063-3, 63850-0064-2",,,,,,
244,*,Everolimus,Pancreatic cancer,EVEROLIMUS tablet,"63850-0062-2, 63850-0062-3, 63850-0063-2, 63850-0063-3, 63850-0064-2",,,,,,
245,*,Everolimus,lung cancer,EVEROLIMUS tablet,"63850-0062-2, 63850-0062-3, 63850-0063-2, 63850-0063-3, 63850-0064-2",,,,,,
246,*,Everolimus,Breast cancer,EVEROLIMUS tablet,"63850-0062-2, 63850-0062-3, 63850-0063-2, 63850-0063-3, 63850-0064-2",,,,,,
247,*,Everolimus,Subependymal giant cell astrocytoma,EVEROLIMUS tablet,"63850-0062-2, 63850-0062-3, 63850-0063-2, 63850-0063-3, 63850-0064-2",,,,,,
248,*,Everolimus,gastrointestinal cancer,EVEROLIMUS tablet,"63850-0058-1, 63850-0059-1, 63850-0060-1, 63850-0061-1",,,,,,
249,*,Everolimus,Renal cell carcinoma,EVEROLIMUS tablet,"63850-0058-1, 63850-0059-1, 63850-0060-1, 63850-0061-1",,sunitinib,,,,
250,*,Everolimus,Pancreatic cancer,EVEROLIMUS tablet,"63850-0058-1, 63850-0059-1, 63850-0060-1, 63850-0061-1",,,,,,
251,*,Everolimus,lung cancer,EVEROLIMUS tablet,"63850-0058-1, 63850-0059-1, 63850-0060-1, 63850-0061-1",,,,,,
252,*,Everolimus,Breast cancer,EVEROLIMUS tablet,"63850-0058-1, 63850-0059-1, 63850-0060-1, 63850-0061-1",,,,,,
253,*,Everolimus,Subependymal giant cell astrocytoma,EVEROLIMUS tablet,"63850-0058-1, 63850-0059-1, 63850-0060-1, 63850-0061-1",,,,,,
254,*,Everolimus,gastrointestinal cancer,EVEROLIMUS tablet,"49884-119-52, 49884-119-91, 49884-125-52, 49884-125-91, 49884-127-52, 49884-127-91",,,,,,
255,*,Everolimus,Renal cell carcinoma,EVEROLIMUS tablet,"49884-119-52, 49884-119-91, 49884-125-52, 49884-125-91, 49884-127-52, 49884-127-91",exemestane,letrozole,,,,
256,*,Everolimus,Renal cell carcinoma,EVEROLIMUS tablet,"49884-119-52, 49884-119-91, 49884-125-52, 49884-125-91, 49884-127-52, 49884-127-91",,,,,,
257,*,Everolimus,Renal cell carcinoma,EVEROLIMUS tablet,"49884-119-52, 49884-119-91, 49884-125-52, 49884-125-91, 49884-127-52, 49884-127-91",,sunitinib,,,,
258,*,Everolimus,Pancreatic cancer,EVEROLIMUS tablet,"49884-119-52, 49884-119-91, 49884-125-52, 49884-125-91, 49884-127-52, 49884-127-91",,,,,,
259,*,Everolimus,lung cancer,EVEROLIMUS tablet,"49884-119-52, 49884-119-91, 49884-125-52, 49884-125-91, 49884-127-52, 49884-127-91",,,,,,
260,*,Everolimus,Breast cancer,EVEROLIMUS tablet,"49884-119-52, 49884-119-91, 49884-125-52, 49884-125-91, 49884-127-52, 49884-127-91",exemestane,letrozole,,,,
261,*,Everolimus,Breast cancer,EVEROLIMUS tablet,"49884-119-52, 49884-119-91, 49884-125-52, 49884-125-91, 49884-127-52, 49884-127-91",,,,,,
262,*,Everolimus,Breast cancer,EVEROLIMUS tablet,"49884-119-52, 49884-119-91, 49884-125-52, 49884-125-91, 49884-127-52, 49884-127-91",,sunitinib,,,,
263,*,Everolimus,Subependymal giant cell astrocytoma,EVEROLIMUS tablet,"49884-119-52, 49884-119-91, 49884-125-52, 49884-125-91, 49884-127-52, 49884-127-91",exemestane,letrozole,,,,
264,*,Everolimus,Subependymal giant cell astrocytoma,EVEROLIMUS tablet,"49884-119-52, 49884-119-91, 49884-125-52, 49884-125-91, 49884-127-52, 49884-127-91",,,,,,
265,*,Everolimus,Subependymal giant cell astrocytoma,EVEROLIMUS tablet,"49884-119-52, 49884-119-91, 49884-125-52, 49884-125-91, 49884-127-52, 49884-127-91",,sunitinib,,,,
266,*,Everolimus,gastrointestinal cancer,EVEROLIMUS tablet,"0093-7766-19, 0093-7766-24, 0093-7767-19, 0093-7767-24, 0093-7768-19, 0093-7768-24",,,,,,
267,sunitinib,Everolimus,Renal cell carcinoma,EVEROLIMUS tablet,"0093-7766-19, 0093-7766-24, 0093-7767-19, 0093-7767-24, 0093-7768-19, 0093-7768-24",,sunitinib,,,,
268,*,Everolimus,Pancreatic cancer,EVEROLIMUS tablet,"0093-7766-19, 0093-7766-24, 0093-7767-19, 0093-7767-24, 0093-7768-19, 0093-7768-24",,,,,,
269,*,Everolimus,lung cancer,EVEROLIMUS tablet,"0093-7766-19, 0093-7766-24, 0093-7767-19, 0093-7767-24, 0093-7768-19, 0093-7768-24",,,,,,
270,*,Everolimus,Breast cancer,EVEROLIMUS tablet,"0093-7766-19, 0093-7766-24, 0093-7767-19, 0093-7767-24, 0093-7768-19, 0093-7768-24",exemestane,letrozole,,,,
271,*,Everolimus,Subependymal giant cell astrocytoma,EVEROLIMUS tablet,"0093-7766-19, 0093-7766-24, 0093-7767-19, 0093-7767-24, 0093-7768-19, 0093-7768-24",,,,,,
272,*,Everolimus,gastrointestinal cancer,AFINITOR- everolimus tablet,"0078-0566-51, 0078-0566-61, 0078-0567-51, 0078-0567-61, 0078-0594-51, 0078-0594-61, 0078-0620-51, 0078-0620-61, 0078-0626-51, 0078-0626-61, 0078-0627-51, 0078-0627-61, 0078-0628-51, 0078-0628-61",,,,,,
273,*,Everolimus,Renal cell carcinoma,AFINITOR- everolimus tablet,"0078-0566-51, 0078-0566-61, 0078-0567-51, 0078-0567-61, 0078-0594-51, 0078-0594-61, 0078-0620-51, 0078-0620-61, 0078-0626-51, 0078-0626-61, 0078-0627-51, 0078-0627-61, 0078-0628-51, 0078-0628-61",,sunitinib,,,,
274,*,Everolimus,Pancreatic cancer,AFINITOR- everolimus tablet,"0078-0566-51, 0078-0566-61, 0078-0567-51, 0078-0567-61, 0078-0594-51, 0078-0594-61, 0078-0620-51, 0078-0620-61, 0078-0626-51, 0078-0626-61, 0078-0627-51, 0078-0627-61, 0078-0628-51, 0078-0628-61",,,,,,
275,*,Everolimus,lung cancer,AFINITOR- everolimus tablet,"0078-0566-51, 0078-0566-61, 0078-0567-51, 0078-0567-61, 0078-0594-51, 0078-0594-61, 0078-0620-51, 0078-0620-61, 0078-0626-51, 0078-0626-61, 0078-0627-51, 0078-0627-61, 0078-0628-51, 0078-0628-61",,,,,,
276,*,Everolimus,Breast cancer,AFINITOR- everolimus tablet,"0078-0566-51, 0078-0566-61, 0078-0567-51, 0078-0567-61, 0078-0594-51, 0078-0594-61, 0078-0620-51, 0078-0620-61, 0078-0626-51, 0078-0626-61, 0078-0627-51, 0078-0627-61, 0078-0628-51, 0078-0628-61",exemestane,letrozole,,,,
277,*,Everolimus,Subependymal giant cell astrocytoma,AFINITOR- everolimus tablet,"0078-0566-51, 0078-0566-61, 0078-0567-51, 0078-0567-61, 0078-0594-51, 0078-0594-61, 0078-0620-51, 0078-0620-61, 0078-0626-51, 0078-0626-61, 0078-0627-51, 0078-0627-61, 0078-0628-51, 0078-0628-61",,,,,,
278,*,Everolimus,gastrointestinal cancer,ZORTRESS- everolimus tablet,"0078-0414-20, 0078-0414-61, 0078-0415-20, 0078-0415-61, 0078-0417-20, 0078-0417-61, 0078-0422-20, 0078-0422-61",,,,,,
279,*,Everolimus,Renal cell carcinoma,ZORTRESS- everolimus tablet,"0078-0414-20, 0078-0414-61, 0078-0415-20, 0078-0415-61, 0078-0417-20, 0078-0417-61, 0078-0422-20, 0078-0422-61",,,,,,
280,*,Everolimus,Pancreatic cancer,ZORTRESS- everolimus tablet,"0078-0414-20, 0078-0414-61, 0078-0415-20, 0078-0415-61, 0078-0417-20, 0078-0417-61, 0078-0422-20, 0078-0422-61",,,,,,
281,*,Everolimus,lung cancer,ZORTRESS- everolimus tablet,"0078-0414-20, 0078-0414-61, 0078-0415-20, 0078-0415-61, 0078-0417-20, 0078-0417-61, 0078-0422-20, 0078-0422-61",,,,,,
282,*,Everolimus,Breast cancer,ZORTRESS- everolimus tablet,"0078-0414-20, 0078-0414-61, 0078-0415-20, 0078-0415-61, 0078-0417-20, 0078-0417-61, 0078-0422-20, 0078-0422-61",,,,,,
283,*,Everolimus,Subependymal giant cell astrocytoma,ZORTRESS- everolimus tablet,"0078-0414-20, 0078-0414-61, 0078-0415-20, 0078-0415-61, 0078-0417-20, 0078-0417-61, 0078-0422-20, 0078-0422-61",,,,,,
284,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,Yes
285,USP,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,Yes
286,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,Yes
287,estrogen receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
288,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
289,USP,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
290,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
291,estrogen and progesterone receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
292,tamoxifen,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
293,Tamoxifen,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
294,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
295,BOXED WARNING,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,tamoxifen,,,,
296,BRCA1,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
297,BRCA2,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
298,Tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
299,USP,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
300,*,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
301,estrogen receptor,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
302,estrogen and progesterone receptor,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
303,tamoxifen,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
304,Tamoxifen,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
305,tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
306,BOXED WARNING,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,tamoxifen,,,,
307,BRCA1,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
308,BRCA2,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"0591-2472-18, 0591-2472-60, 0591-2473-19, 0591-2473-30",,,,,,
309,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","59651-299-60, 59651-300-30, 59651-300-90",,,,,,
310,*,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","59651-299-60, 59651-300-30, 59651-300-90",,,,,,
311,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","70771-1184-1, 70771-1184-6, 70771-1184-8, 70771-1184-9, 70771-1185-0, 70771-1185-1, 70771-1185-3, 70771-1185-6, 70771-1185-9",,,,,,
312,*,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","70771-1184-1, 70771-1184-6, 70771-1184-8, 70771-1184-9, 70771-1185-0, 70771-1185-1, 70771-1185-3, 70771-1185-6, 70771-1185-9",,,,,,
313,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","51862-446-01, 51862-446-05, 51862-446-10, 51862-446-30, 51862-447-05, 51862-447-10, 51862-447-18, 51862-447-60",,,,,,Yes
314,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","51862-446-01, 51862-446-05, 51862-446-10, 51862-446-30, 51862-447-05, 51862-447-10, 51862-447-18, 51862-447-60",,,,,,Yes
315,estrogen receptor,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","51862-446-01, 51862-446-05, 51862-446-10, 51862-446-30, 51862-447-05, 51862-447-10, 51862-447-18, 51862-447-60",,,,,,
316,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","51862-446-01, 51862-446-05, 51862-446-10, 51862-446-30, 51862-447-05, 51862-447-10, 51862-447-18, 51862-447-60",,,,,,
317,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","51862-446-01, 51862-446-05, 51862-446-10, 51862-446-30, 51862-447-05, 51862-447-10, 51862-447-18, 51862-447-60",,,,,,
318,estrogen and progesterone receptor,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","51862-446-01, 51862-446-05, 51862-446-10, 51862-446-30, 51862-447-05, 51862-447-10, 51862-447-18, 51862-447-60",,,,,,
319,tamoxifen,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","51862-446-01, 51862-446-05, 51862-446-10, 51862-446-30, 51862-447-05, 51862-447-10, 51862-447-18, 51862-447-60",,,,,,
320,Tamoxifen,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","51862-446-01, 51862-446-05, 51862-446-10, 51862-446-30, 51862-447-05, 51862-447-10, 51862-447-18, 51862-447-60",,,,,,
321,BOXED WARNING,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","51862-446-01, 51862-446-05, 51862-446-10, 51862-446-30, 51862-447-05, 51862-447-10, 51862-447-18, 51862-447-60",,tamoxifen,,,,
322,BRCA1,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","51862-446-01, 51862-446-05, 51862-446-10, 51862-446-30, 51862-447-05, 51862-447-10, 51862-447-18, 51862-447-60",,,,,,
323,BRCA2,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","51862-446-01, 51862-446-05, 51862-446-10, 51862-446-30, 51862-447-05, 51862-447-10, 51862-447-18, 51862-447-60",,,,,,
324,tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","51862-446-01, 51862-446-05, 51862-446-10, 51862-446-30, 51862-447-05, 51862-447-10, 51862-447-18, 51862-447-60",,,,,,
325,BOXED WARNING,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","51862-446-01, 51862-446-05, 51862-446-10, 51862-446-30, 51862-447-05, 51862-447-10, 51862-447-18, 51862-447-60",,,,,,
326,*,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","51862-446-01, 51862-446-05, 51862-446-10, 51862-446-30, 51862-447-05, 51862-447-10, 51862-447-18, 51862-447-60",,,,,,
327,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,Yes
328,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,Yes
329,estrogen receptor,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
330,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
331,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
332,estrogen and progesterone receptor,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
333,tamoxifen,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
334,Tamoxifen,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
335,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
336,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,tamoxifen,,,,
337,BRCA1,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
338,BRCA2,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
339,Tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
340,*,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
341,estrogen receptor,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
342,estrogen and progesterone receptor,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
343,tamoxifen,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
344,Tamoxifen,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
345,tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
346,*,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,tamoxifen,,,,
347,BRCA1,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
348,BRCA2,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","68382-826-01, 68382-826-14, 68382-826-16, 68382-826-28, 68382-827-01, 68382-827-06, 68382-827-10, 68382-827-14, 68382-827-16",,,,,,
349,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0378-0144-91, 0378-0274-93",,,,,,Yes
350,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0378-0144-91, 0378-0274-93",,,,,,Yes
351,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0378-0144-91, 0378-0274-93",,,,,,
352,estrogen receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0378-0144-91, 0378-0274-93",,,,,,
353,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0378-0144-91, 0378-0274-93",,,,,,
354,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0378-0144-91, 0378-0274-93",,,,,,
355,progesterone-receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0378-0144-91, 0378-0274-93",,,,,,
356,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0378-0144-91, 0378-0274-93",,tamoxifen citrate,,,,
357,tamoxifen,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0378-0144-91, 0378-0274-93",,,,,,
358,BRCA1,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0378-0144-91, 0378-0274-93",,,,,,
359,BRCA2,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"0378-0144-91, 0378-0274-93",,,,,,
360,tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"0378-0144-91, 0378-0274-93",,,,,,
361,*,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"0378-0144-91, 0378-0274-93",,,,,,
362,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,,,,,Yes
363,*,Tamoxifen Citrate,Breast cancer,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,,,,,Yes
364,estrogen receptor,Tamoxifen Citrate,Breast cancer,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,,,,,
365,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,,,,,
366,*,Tamoxifen Citrate,Breast cancer,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,,,,,
367,Tamoxifen,Tamoxifen Citrate,Breast cancer,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,,,,,
368,estrogen and progesterone receptor,Tamoxifen Citrate,Breast cancer,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,,,,,
369,tamoxifen,Tamoxifen Citrate,Breast cancer,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,,,,,
370,*,Tamoxifen Citrate,Breast cancer,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,tamoxifen,,,,
371,BRCA1,Tamoxifen Citrate,Breast cancer,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,tamoxifen,,,,
372,BRCA2,Tamoxifen Citrate,Breast cancer,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,tamoxifen,,,,
373,Tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,,,,,
374,*,Tamoxifen Citrate,Ductal carcinoma in situ,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,,,,,
375,estrogen receptor,Tamoxifen Citrate,Ductal carcinoma in situ,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,,,,,
376,Tamoxifen,Tamoxifen Citrate,Ductal carcinoma in situ,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,,,,,
377,estrogen and progesterone receptor,Tamoxifen Citrate,Ductal carcinoma in situ,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,,,,,
378,tamoxifen,Tamoxifen Citrate,Ductal carcinoma in situ,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,,,,,
379,*,Tamoxifen Citrate,Ductal carcinoma in situ,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,tamoxifen,,,,
380,BRCA1,Tamoxifen Citrate,Ductal carcinoma in situ,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,tamoxifen,,,,
381,BRCA2,Tamoxifen Citrate,Ductal carcinoma in situ,tamoxifen citrate- Tamoxifen Citrate tablet,"62037-964-18, 62037-964-25, 62037-964-60, 62037-965-12, 62037-965-30, 62037-965-90",,tamoxifen,,,,
382,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,Yes
383,USP,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,Yes
384,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,Yes
385,estrogen receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
386,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
387,USP,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
388,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
389,estrogen and progesterone receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
390,tamoxifen,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
391,Tamoxifen,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
392,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
393,BOXED WARNING,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0942-0,,tamoxifen,,,,
394,BRCA1,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
395,BRCA2,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
396,Tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
397,USP,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
398,*,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
399,estrogen receptor,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
400,estrogen and progesterone receptor,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
401,tamoxifen,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
402,Tamoxifen,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
403,tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
404,BOXED WARNING,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0942-0,,tamoxifen,,,,
405,BRCA1,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
406,BRCA2,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0942-0,,,,,,
407,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,Yes
408,USP,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,Yes
409,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,Yes
410,estrogen receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
411,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
412,USP,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
413,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
414,estrogen and progesterone receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
415,tamoxifen,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
416,Tamoxifen,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
417,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
418,BOXED WARNING,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0485-1,,tamoxifen,,,,
419,BRCA1,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
420,BRCA2,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
421,Tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
422,USP,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
423,*,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
424,estrogen receptor,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
425,estrogen and progesterone receptor,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
426,tamoxifen,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
427,Tamoxifen,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
428,tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
429,BOXED WARNING,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0485-1,,tamoxifen,,,,
430,BRCA1,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
431,BRCA2,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,50090-0485-1,,,,,,
432,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"71335-0893-1, 71335-0893-2, 71335-0893-3, 71335-0893-4, 71335-0893-5, 71335-0893-6",,,,,,Yes
433,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"71335-0893-1, 71335-0893-2, 71335-0893-3, 71335-0893-4, 71335-0893-5, 71335-0893-6",,,,,,Yes
434,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"71335-0893-1, 71335-0893-2, 71335-0893-3, 71335-0893-4, 71335-0893-5, 71335-0893-6",,,,,,
435,estrogen receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"71335-0893-1, 71335-0893-2, 71335-0893-3, 71335-0893-4, 71335-0893-5, 71335-0893-6",,,,,,
436,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"71335-0893-1, 71335-0893-2, 71335-0893-3, 71335-0893-4, 71335-0893-5, 71335-0893-6",,,,,,
437,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"71335-0893-1, 71335-0893-2, 71335-0893-3, 71335-0893-4, 71335-0893-5, 71335-0893-6",,,,,,
438,progesterone-receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"71335-0893-1, 71335-0893-2, 71335-0893-3, 71335-0893-4, 71335-0893-5, 71335-0893-6",,,,,,
439,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"71335-0893-1, 71335-0893-2, 71335-0893-3, 71335-0893-4, 71335-0893-5, 71335-0893-6",,tamoxifen citrate,,,,
440,tamoxifen,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"71335-0893-1, 71335-0893-2, 71335-0893-3, 71335-0893-4, 71335-0893-5, 71335-0893-6",,,,,,
441,BRCA1,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"71335-0893-1, 71335-0893-2, 71335-0893-3, 71335-0893-4, 71335-0893-5, 71335-0893-6",,,,,,
442,BRCA2,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"71335-0893-1, 71335-0893-2, 71335-0893-3, 71335-0893-4, 71335-0893-5, 71335-0893-6",,,,,,
443,tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"71335-0893-1, 71335-0893-2, 71335-0893-3, 71335-0893-4, 71335-0893-5, 71335-0893-6",,,,,,
444,*,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"71335-0893-1, 71335-0893-2, 71335-0893-3, 71335-0893-4, 71335-0893-5, 71335-0893-6",,,,,,
445,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-0237-1, 71335-0237-2, 71335-0237-3, 71335-0237-4, 71335-0237-5, 71335-0237-6",,,,,,Yes
446,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-0237-1, 71335-0237-2, 71335-0237-3, 71335-0237-4, 71335-0237-5, 71335-0237-6",,,,,,Yes
447,estrogen receptor,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-0237-1, 71335-0237-2, 71335-0237-3, 71335-0237-4, 71335-0237-5, 71335-0237-6",,,,,,
448,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-0237-1, 71335-0237-2, 71335-0237-3, 71335-0237-4, 71335-0237-5, 71335-0237-6",,,,,,
449,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-0237-1, 71335-0237-2, 71335-0237-3, 71335-0237-4, 71335-0237-5, 71335-0237-6",,,,,,
450,estrogen and progesterone receptor,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-0237-1, 71335-0237-2, 71335-0237-3, 71335-0237-4, 71335-0237-5, 71335-0237-6",,,,,,
451,tamoxifen,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-0237-1, 71335-0237-2, 71335-0237-3, 71335-0237-4, 71335-0237-5, 71335-0237-6",,,,,,
452,Tamoxifen,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-0237-1, 71335-0237-2, 71335-0237-3, 71335-0237-4, 71335-0237-5, 71335-0237-6",,,,,,
453,BOXED WARNING,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-0237-1, 71335-0237-2, 71335-0237-3, 71335-0237-4, 71335-0237-5, 71335-0237-6",,tamoxifen,,,,
454,BRCA1,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-0237-1, 71335-0237-2, 71335-0237-3, 71335-0237-4, 71335-0237-5, 71335-0237-6",,,,,,
455,BRCA2,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-0237-1, 71335-0237-2, 71335-0237-3, 71335-0237-4, 71335-0237-5, 71335-0237-6",,,,,,
456,tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","71335-0237-1, 71335-0237-2, 71335-0237-3, 71335-0237-4, 71335-0237-5, 71335-0237-6",,,,,,
457,BOXED WARNING,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","71335-0237-1, 71335-0237-2, 71335-0237-3, 71335-0237-4, 71335-0237-5, 71335-0237-6",,,,,,
458,*,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","71335-0237-1, 71335-0237-2, 71335-0237-3, 71335-0237-4, 71335-0237-5, 71335-0237-6",,,,,,
459,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,Yes
460,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,Yes
461,estrogen receptor,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
462,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
463,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
464,estrogen and progesterone receptor,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
465,tamoxifen,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
466,Tamoxifen,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
467,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
468,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,tamoxifen,,,,
469,BRCA1,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
470,BRCA2,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
471,Tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
472,*,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
473,estrogen receptor,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
474,estrogen and progesterone receptor,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
475,tamoxifen,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
476,Tamoxifen,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
477,tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
478,*,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,tamoxifen,,,,
479,BRCA1,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
480,BRCA2,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","71335-1424-1, 71335-1424-2, 71335-1424-3, 71335-1424-4, 71335-1424-5, 71335-1424-6",,,,,,
481,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","60429-909-60, 60429-910-30",,,,,,Yes
482,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","60429-909-60, 60429-910-30",,,,,,Yes
483,estrogen receptor,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","60429-909-60, 60429-910-30",,,,,,
484,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","60429-909-60, 60429-910-30",,,,,,
485,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","60429-909-60, 60429-910-30",,,,,,
486,estrogen and progesterone receptor,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","60429-909-60, 60429-910-30",,,,,,
487,tamoxifen,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","60429-909-60, 60429-910-30",,,,,,
488,Tamoxifen,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","60429-909-60, 60429-910-30",,,,,,
489,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","60429-909-60, 60429-910-30",,tamoxifen,,,,
490,BRCA1,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","60429-909-60, 60429-910-30",,,,,,
491,BRCA2,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","60429-909-60, 60429-910-30",,,,,,
492,tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","60429-909-60, 60429-910-30",,,,,,
493,*,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","60429-909-60, 60429-910-30",,,,,,
494,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","63739-269-10, 63739-269-42",,,,,,Yes
495,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","63739-269-10, 63739-269-42",,,,,,Yes
496,estrogen receptor,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","63739-269-10, 63739-269-42",,,,,,
497,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","63739-269-10, 63739-269-42",,,,,,
498,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","63739-269-10, 63739-269-42",,,,,,
499,estrogen and progesterone receptor,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","63739-269-10, 63739-269-42",,,,,,
500,tamoxifen,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","63739-269-10, 63739-269-42",,,,,,
501,Tamoxifen,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","63739-269-10, 63739-269-42",,,,,,
502,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","63739-269-10, 63739-269-42",,tamoxifen,,,,
503,BRCA1,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","63739-269-10, 63739-269-42",,,,,,
504,BRCA2,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","63739-269-10, 63739-269-42",,,,,,
505,tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","63739-269-10, 63739-269-42",,,,,,
506,*,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","63739-269-10, 63739-269-42",,,,,,
507,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","54868-3004-2, 54868-3004-3, 54868-3004-4, 54868-3004-5, 54868-4287-0, 54868-4287-1, 54868-4287-2, 54868-4287-3, 54868-4287-4",,,,,,Yes
508,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","54868-3004-2, 54868-3004-3, 54868-3004-4, 54868-3004-5, 54868-4287-0, 54868-4287-1, 54868-4287-2, 54868-4287-3, 54868-4287-4",,,,,,Yes
509,estrogen receptor,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","54868-3004-2, 54868-3004-3, 54868-3004-4, 54868-3004-5, 54868-4287-0, 54868-4287-1, 54868-4287-2, 54868-4287-3, 54868-4287-4",,,,,,
510,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","54868-3004-2, 54868-3004-3, 54868-3004-4, 54868-3004-5, 54868-4287-0, 54868-4287-1, 54868-4287-2, 54868-4287-3, 54868-4287-4",,,,,,
511,*,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","54868-3004-2, 54868-3004-3, 54868-3004-4, 54868-3004-5, 54868-4287-0, 54868-4287-1, 54868-4287-2, 54868-4287-3, 54868-4287-4",,,,,,
512,estrogen and progesterone receptor,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","54868-3004-2, 54868-3004-3, 54868-3004-4, 54868-3004-5, 54868-4287-0, 54868-4287-1, 54868-4287-2, 54868-4287-3, 54868-4287-4",,,,,,
513,tamoxifen,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","54868-3004-2, 54868-3004-3, 54868-3004-4, 54868-3004-5, 54868-4287-0, 54868-4287-1, 54868-4287-2, 54868-4287-3, 54868-4287-4",,,,,,
514,Tamoxifen,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","54868-3004-2, 54868-3004-3, 54868-3004-4, 54868-3004-5, 54868-4287-0, 54868-4287-1, 54868-4287-2, 54868-4287-3, 54868-4287-4",,,,,,
515,BOXED WARNING,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","54868-3004-2, 54868-3004-3, 54868-3004-4, 54868-3004-5, 54868-4287-0, 54868-4287-1, 54868-4287-2, 54868-4287-3, 54868-4287-4",,tamoxifen,,,,
516,BRCA1,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","54868-3004-2, 54868-3004-3, 54868-3004-4, 54868-3004-5, 54868-4287-0, 54868-4287-1, 54868-4287-2, 54868-4287-3, 54868-4287-4",,,,,,
517,BRCA2,Tamoxifen Citrate,Breast cancer,"TAMOXIFEN CITRATE tablet, film coated","54868-3004-2, 54868-3004-3, 54868-3004-4, 54868-3004-5, 54868-4287-0, 54868-4287-1, 54868-4287-2, 54868-4287-3, 54868-4287-4",,,,,,
518,tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","54868-3004-2, 54868-3004-3, 54868-3004-4, 54868-3004-5, 54868-4287-0, 54868-4287-1, 54868-4287-2, 54868-4287-3, 54868-4287-4",,,,,,
519,BOXED WARNING,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","54868-3004-2, 54868-3004-3, 54868-3004-4, 54868-3004-5, 54868-4287-0, 54868-4287-1, 54868-4287-2, 54868-4287-3, 54868-4287-4",,,,,,
520,*,Tamoxifen Citrate,Ductal carcinoma in situ,"TAMOXIFEN CITRATE tablet, film coated","54868-3004-2, 54868-3004-3, 54868-3004-4, 54868-3004-5, 54868-4287-0, 54868-4287-1, 54868-4287-2, 54868-4287-3, 54868-4287-4",,,,,,
521,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,Yes
522,USP,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,Yes
523,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,Yes
524,estrogen receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
525,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
526,USP,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
527,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
528,estrogen and progesterone receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
529,tamoxifen,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
530,Tamoxifen,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
531,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
532,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5254-3,,tamoxifen,,,,
533,BRCA1,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
534,BRCA2,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
535,Tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
536,USP,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
537,*,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
538,estrogen receptor,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
539,estrogen and progesterone receptor,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
540,tamoxifen,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
541,Tamoxifen,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
542,tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
543,*,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5254-3,,tamoxifen,,,,
544,BRCA1,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
545,BRCA2,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5254-3,,,,,,
546,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,Yes
547,USP,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,Yes
548,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,Yes
549,estrogen receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
550,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
551,USP,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
552,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
553,estrogen and progesterone receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
554,tamoxifen,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
555,Tamoxifen,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
556,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
557,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5005-3,,tamoxifen,,,,
558,BRCA1,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
559,BRCA2,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
560,Tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
561,USP,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
562,*,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
563,estrogen receptor,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
564,estrogen and progesterone receptor,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
565,tamoxifen,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
566,Tamoxifen,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
567,tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
568,*,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5005-3,,tamoxifen,,,,
569,BRCA1,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
570,BRCA2,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,68071-5005-3,,,,,,
571,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,,,,,Yes
572,USP,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,,,,,Yes
573,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,,,,,Yes
574,estrogen receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,,,,,
575,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,,,,,
576,USP,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,,,,,
577,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,,,,,
578,estrogen and progesterone receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,,,,,
579,tamoxifen,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,,,,,
580,Tamoxifen,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,,,,,
581,BOXED WARNING,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,tamoxifen,,,,
582,BRCA1,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,,,,,
583,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,,,,,
584,BRCA2,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,,,,,
585,tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,,,,,
586,BOXED WARNING,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,,,,,
587,*,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"63187-976-30, 63187-976-60, 63187-976-90",,,,,,
588,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"70518-2721-0, 70518-2721-1",,,,,,Yes
589,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"70518-2721-0, 70518-2721-1",,,,,,Yes
590,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"70518-2721-0, 70518-2721-1",,,,,,
591,estrogen receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"70518-2721-0, 70518-2721-1",,,,,,
592,Tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"70518-2721-0, 70518-2721-1",,,,,,
593,*,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"70518-2721-0, 70518-2721-1",,,,,,
594,progesterone-receptor,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"70518-2721-0, 70518-2721-1",,,,,,
595,tamoxifen citrate,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"70518-2721-0, 70518-2721-1",,tamoxifen citrate,,,,
596,tamoxifen,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"70518-2721-0, 70518-2721-1",,,,,,
597,BRCA1,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"70518-2721-0, 70518-2721-1",,,,,,
598,BRCA2,Tamoxifen Citrate,Breast cancer,TAMOXIFEN CITRATE tablet,"70518-2721-0, 70518-2721-1",,,,,,
599,tamoxifen citrate,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"70518-2721-0, 70518-2721-1",,,,,,
600,*,Tamoxifen Citrate,Ductal carcinoma in situ,TAMOXIFEN CITRATE tablet,"70518-2721-0, 70518-2721-1",,,,,,
601,*,Tamoxifen Citrate,Breast cancer,SOLTAMOX- tamoxifen citrate liquid,89141-123-01,,,,,,Yes
602,*,Tamoxifen Citrate,Breast cancer,SOLTAMOX- tamoxifen citrate liquid,89141-123-01,,,,,,
603,*,Tamoxifen Citrate,Ductal carcinoma in situ,SOLTAMOX- tamoxifen citrate liquid,89141-123-01,,,,,,
604,*,Toremifene,Breast cancer,FARESTON- toremifene citrate tablet,"42747-327-30, 42747-327-72",,,,,,Yes
605,ER/PR,Trastuzumab,Breast cancer,HERCEPTIN- trastuzumab kit,"50242-132-01, 50242-132-10, 50242-134-68",,,,,,
606,HER2,Trastuzumab,Breast cancer,HERCEPTIN- trastuzumab kit,"50242-132-01, 50242-132-10, 50242-134-68",,,,,,
607,Herceptin,Trastuzumab,Breast cancer,HERCEPTIN- trastuzumab kit,"50242-132-01, 50242-132-10, 50242-134-68",,,,,,
608,*,Trastuzumab,Breast cancer,HERCEPTIN- trastuzumab kit,"50242-132-01, 50242-132-10, 50242-134-68",paclitaxel,,Yes,,,Yes
609,ER/PR,Trastuzumab,gastroesophageal junction adenocarcinoma,HERCEPTIN- trastuzumab kit,"50242-132-01, 50242-132-10, 50242-134-68",,,,,,
610,HER2,Trastuzumab,gastroesophageal junction adenocarcinoma,HERCEPTIN- trastuzumab kit,"50242-132-01, 50242-132-10, 50242-134-68",,,,,,
611,Herceptin,Trastuzumab,gastroesophageal junction adenocarcinoma,HERCEPTIN- trastuzumab kit,"50242-132-01, 50242-132-10, 50242-134-68",,,,,,
612,*,Trastuzumab,gastroesophageal junction adenocarcinoma,HERCEPTIN- trastuzumab kit,"50242-132-01, 50242-132-10, 50242-134-68",paclitaxel,,,,,
613,*,Trastuzumab,gastroesophageal junction adenocarcinoma,HERCEPTIN- trastuzumab kit,"50242-132-01, 50242-132-10, 50242-134-68","cisplatin, 5-fluorouracil, capecitabine",,,,,
614,*,Trastuzumab,Stomach adenocarcinoma,HERCEPTIN- trastuzumab kit,"50242-132-01, 50242-132-10, 50242-134-68",,,,,,
615,human epidermal growth factor receptor 2,Fulvestrant,Breast cancer,FASLODEX- fulvestrant injection,0310-0720-10,,,,,,
616,*,Fulvestrant,Breast cancer,FASLODEX- fulvestrant injection,0310-0720-10,,,,,,Yes
617,*,Anastrozole,Breast cancer,ANASTROZOLE- anastrozole tablets tablet,"69117-0003-1, 69117-0003-4",,,,,,
618,hormone receptor,Anastrozole,Breast cancer,ANASTROZOLE- anastrozole tablets tablet,"69117-0003-1, 69117-0003-4",,,Yes,,,Yes
619,*,Anastrozole,Breast cancer,ANASTROZOLE- anastrozole tablets tablet,"69117-0003-1, 69117-0003-4",,tamoxifen,,,,
620,*,Anastrozole,Breast cancer,ANASTROZOLE tablet,"16729-035-10, 16729-035-15, 16729-035-16, 16729-035-17",,,,,,
621,hormone receptor,Anastrozole,Breast cancer,ANASTROZOLE tablet,"16729-035-10, 16729-035-15, 16729-035-16, 16729-035-17",,,Yes,,,Yes
622,*,Anastrozole,Breast cancer,ANASTROZOLE tablet,"16729-035-10, 16729-035-15, 16729-035-16, 16729-035-17",,tamoxifen,,,,
623,*,Anastrozole,Breast cancer,ANASTROZOLE tablet,67877-171-30,,,,,,
624,*,Anastrozole,Breast cancer,ANASTROZOLE tablet,67877-171-10,,,,,,
625,*,Anastrozole,Breast cancer,ANASTROZOLE tablet,"51991-620-10, 51991-620-33",,,,,,
626,hormone receptor,Anastrozole,Breast cancer,ANASTROZOLE tablet,"51991-620-10, 51991-620-33",,,Yes,,,Yes
627,*,Anastrozole,Breast cancer,ANASTROZOLE tablet,"51991-620-10, 51991-620-33",,tamoxifen,,,,
628,*,Anastrozole,Breast cancer,"ANASTROZOLE tablet, coated","68001-155-04, 68001-155-08",,,,,,
629,hormone receptor,Anastrozole,Breast cancer,"ANASTROZOLE tablet, coated","68001-155-04, 68001-155-08",,,,,,Yes
630,*,Anastrozole,Breast cancer,"ANASTROZOLE tablet, coated","68001-155-04, 68001-155-08",,tamoxifen,,,,
631,*,Anastrozole,Breast cancer,"ANASTROZOLE tablet, coated",62033-0376-6,,,,,,
632,hormone receptor,Anastrozole,Breast cancer,"ANASTROZOLE tablet, coated",62033-0376-6,,,,,,Yes
633,*,Anastrozole,Breast cancer,"ANASTROZOLE tablet, coated",62033-0376-6,,tamoxifen,,,,
634,*,Anastrozole,Breast cancer,"ANASTROZOLE tablet, coated","65841-743-06, 65841-743-10",,,,,,
635,*,Anastrozole,Breast cancer,"ANASTROZOLE tablet, coated","68382-209-06, 68382-209-10",,,,,,
636,hormone receptor,Anastrozole,Breast cancer,"ANASTROZOLE tablet, coated","68382-209-06, 68382-209-10",,,,,,Yes
637,*,Anastrozole,Breast cancer,"ANASTROZOLE tablet, coated","68382-209-06, 68382-209-10",,tamoxifen,,,,
638,*,Anastrozole,Breast cancer,"ANASTROZOLE tablet, film coated","59651-236-30, 59651-236-90",,,,,,
639,*,Anastrozole,Breast cancer,"ANASTROZOLE tablet, film coated","59651-236-30, 59651-236-90",,,,,,Yes
640,*,Anastrozole,Breast cancer,"ANASTROZOLE tablet, film coated","59651-236-30, 59651-236-90",,tamoxifen,,,,
641,*,Anastrozole,Breast cancer,"ANASTROZOLE tablet, film coated",62175-710-32,,,,,,
642,hormone receptor,Anastrozole,Breast cancer,"ANASTROZOLE tablet, film coated",62175-710-32,,,,,,Yes
643,*,Anastrozole,Breast cancer,"ANASTROZOLE tablet, film coated",62175-710-32,,tamoxifen,,,,
644,*,Anastrozole,Breast cancer,"ANASTROZOLE tablet, film coated",63672-0015-0,,,,,,
645,hormone receptor,Anastrozole,Breast cancer,"ANASTROZOLE tablet, film coated",63672-0015-0,,,,,,Yes
646,*,Anastrozole,Breast cancer,"ANASTROZOLE tablet, film coated",63672-0015-0,,tamoxifen,,,,
647,*,Anastrozole,Breast cancer,"ANASTROZOLE tablet, film coated",0093-7536-56,,,,,,
648,hormone receptor,Anastrozole,Breast cancer,"ANASTROZOLE tablet, film coated",0093-7536-56,,,,,,Yes
649,*,Anastrozole,Breast cancer,"ANASTROZOLE tablet, film coated",0093-7536-56,,tamoxifen,,,,
650,*,Anastrozole,Breast cancer,ANASTROZOLE tablet,76519-1224-3,,,,,,
651,*,Anastrozole,Breast cancer,ANASTROZOLE tablet,"63850-0010-1, 63850-0010-2",,,,,,
652,hormone receptor,Anastrozole,Breast cancer,ANASTROZOLE tablet,"63850-0010-1, 63850-0010-2",,,Yes,,,Yes
653,*,Anastrozole,Breast cancer,ANASTROZOLE tablet,"63850-0010-1, 63850-0010-2",,tamoxifen,,,,
654,*,Anastrozole,Breast cancer,ANASTROZOLE tablet,16571-421-03,,,,,,
655,*,Anastrozole,Breast cancer,ANASTROZOLE tablet,60763-376-06,,,,,,
656,hormone receptor,Anastrozole,Breast cancer,ANASTROZOLE tablet,60763-376-06,,,,,,Yes
657,*,Anastrozole,Breast cancer,ANASTROZOLE tablet,60763-376-06,,tamoxifen,,,,
658,*,Anastrozole,Breast cancer,TESTOSTERONE / ANASTROZOLE pellet,"69761-222-12, 69761-222-30",,,,,,
659,*,Anastrozole,Breast cancer,ANASTROZOLE tablet,"76420-004-12, 76420-004-15, 76420-004-20, 76420-004-30",,,,,,
660,hormone receptor,Anastrozole,Breast cancer,ANASTROZOLE tablet,"76420-004-12, 76420-004-15, 76420-004-20, 76420-004-30",,,Yes,,,Yes
661,*,Anastrozole,Breast cancer,ANASTROZOLE tablet,"76420-004-12, 76420-004-15, 76420-004-20, 76420-004-30",,tamoxifen,,,,
662,*,Anastrozole,Breast cancer,ANASTROZOLE tablet,"50090-5002-0, 50090-5002-1",,,,,,
663,hormone receptor,Anastrozole,Breast cancer,ANASTROZOLE tablet,"50090-5002-0, 50090-5002-1",,,Yes,,,Yes
664,*,Anastrozole,Breast cancer,ANASTROZOLE tablet,"50090-5002-0, 50090-5002-1",,tamoxifen,,,,
665,*,Exemestane,Breast cancer,EXEMESTANE tablet,47781-108-30,,,,,,
666,*,Exemestane,Breast cancer,EXEMESTANE tablet,70771-1374-3,,,,,,
667,*,Exemestane,Breast cancer,EXEMESTANE tablet,69097-316-02,,,,,,
668,*,Exemestane,Breast cancer,EXEMESTANE tablet,44278-025-30,,,,,,
669,*,Exemestane,Breast cancer,"EXEMESTANE tablet, film coated",65162-240-03,,,,,,
670,*,Exemestane,Breast cancer,"EXEMESTANE tablet, film coated","51991-005-33, 51991-005-90",,,,,,
671,*,Exemestane,Breast cancer,"EXEMESTANE tablet, film coated",71921-190-33,,,,,,
672,*,Exemestane,Breast cancer,"EXEMESTANE tablet, film coated",0378-5001-93,,,,,,
673,*,Exemestane,Breast cancer,"EXEMESTANE tablet, film coated",0054-0080-13,,,,,,
674,*,Exemestane,Breast cancer,"EXEMESTANE tablet, sugar coated",59762-2858-1,,,,,,
675,*,Exemestane,Breast cancer,EXEMESTANE tablet,0832-0595-30,,,,,,
676,*,Exemestane,Breast cancer,EXEMESTANE tablet,68382-383-06,,,,,,
677,*,Exemestane,Breast cancer,AROMASIN- exemestane tablet,54868-5261-0,,,,,,
678,*,Exemestane,Breast cancer,EXEMESTANE tablet,50090-5193-0,,,,,,
679,*,Exemestane,Breast cancer,"EXEMESTANE tablet, film coated",63629-2056-1,,,,,,
680,*,Exemestane,Breast cancer,AROMASIN- exemestane tablet,0009-7663-04,,,,,,
681,HER2,Lapatinib Ditosylate,Breast cancer,TYKERB- lapatinib tablet,0078-0671-19,"anthracycline, taxane, trastuzumab, capecitabine",,,,,Yes
682,human epidermal growth factor receptor 2,Lapatinib Ditosylate,Breast cancer,TYKERB- lapatinib tablet,0078-0671-19,"anthracycline, taxane, trastuzumab, capecitabine",,,,,Yes
683,*,Lapatinib Ditosylate,Breast cancer,TYKERB- lapatinib tablet,0078-0671-19,capecitabine,,,,,
684,HER2 receptor,Lapatinib Ditosylate,Breast cancer,TYKERB- lapatinib tablet,0078-0671-19,,,,,,Yes
685,aromatase,Lapatinib Ditosylate,Breast cancer,TYKERB- lapatinib tablet,0078-0671-19,,aromatase,,,,Yes
686,hormone receptor positive early breast cancer,Letrozole,Breast cancer,"LETROZOLE- letrozole tablets tablet, film coated",69117-0004-1,,,,,,
687,USP,Letrozole,Breast cancer,"LETROZOLE- letrozole tablets tablet, film coated",69117-0004-1,,,,,,
688,*,Letrozole,Breast cancer,"LETROZOLE- letrozole tablets tablet, film coated",69117-0004-1,,,,,,
689,USP,Letrozole,Breast cancer,"LETROZOLE- letrozole tablets tablet, film coated",69117-0004-1,,,Yes,,,Yes
690,hormone receptor positive early breast cancer,Letrozole,Breast cancer,LETROZOLE tablet,"51991-759-10, 51991-759-33",,,,,,
691,*,Letrozole,Breast cancer,LETROZOLE tablet,"51991-759-10, 51991-759-33",,,,,,
692,*,Letrozole,Breast cancer,LETROZOLE tablet,"51991-759-10, 51991-759-33",,,Yes,,,Yes
693,hormone receptor positive early breast cancer,Letrozole,Breast cancer,"LETROZOLE tablet, film coated","16729-034-01, 16729-034-10, 16729-034-15, 16729-034-16, 16729-034-17, 16729-034-43",,,,,,
694,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated","16729-034-01, 16729-034-10, 16729-034-15, 16729-034-16, 16729-034-17, 16729-034-43",,,,,,
695,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated","16729-034-01, 16729-034-10, 16729-034-15, 16729-034-16, 16729-034-17, 16729-034-43",,,,,,Yes
696,USP,Letrozole,Breast cancer,"LETROZOLE tablet, film coated","60505-3255-1, 60505-3255-3, 60505-3255-8",,,,,,Yes
697,USP,Letrozole,Breast cancer,"LETROZOLE tablet, film coated","60505-3255-1, 60505-3255-3, 60505-3255-8",,,,,,
698,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",24535-0801-1,,,,,,
699,USP,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",24535-0801-1,,,,,,
700,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated","59651-180-30, 59651-180-90",,,,,,
701,hormone receptor positive early breast cancer,Letrozole,Breast cancer,"LETROZOLE tablet, film coated","55111-646-30, 55111-646-78, 55111-646-79",,,,,,
702,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated","55111-646-30, 55111-646-78, 55111-646-79",,,,,,
703,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated","55111-646-30, 55111-646-78, 55111-646-79",,,,,,Yes
704,hormone receptor positive early breast cancer,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",0093-7620-56,,,,,,
705,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",0093-7620-56,,,,,,
706,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",0093-7620-56,,,,,,Yes
707,hormone receptor positive early breast cancer,Letrozole,Breast cancer,LETROZOLE tablet,"24724-030-01, 24724-030-03",,,,,,
708,*,Letrozole,Breast cancer,LETROZOLE tablet,"24724-030-01, 24724-030-03",,,,,,
709,*,Letrozole,Breast cancer,LETROZOLE tablet,"24724-030-01, 24724-030-03",,,Yes,,,Yes
710,hormone receptor positive early breast cancer,Letrozole,Breast cancer,LETROZOLE tablet,57884-2021-1,,,,,,
711,*,Letrozole,Breast cancer,LETROZOLE tablet,57884-2021-1,,,,,,
712,*,Letrozole,Breast cancer,LETROZOLE tablet,57884-2021-1,,,Yes,,,Yes
713,hormone receptor positive early breast cancer,Letrozole,Breast cancer,LETROZOLE tablet,"63850-0025-1, 63850-0025-4",,,,,,
714,*,Letrozole,Breast cancer,LETROZOLE tablet,"63850-0025-1, 63850-0025-4",,,,,,
715,*,Letrozole,Breast cancer,LETROZOLE tablet,"63850-0025-1, 63850-0025-4",,,Yes,,,Yes
716,hormone receptor positive early breast cancer,Letrozole,Breast cancer,LETROZOLE tablet,"50268-476-11, 50268-476-15",,,,,,
717,*,Letrozole,Breast cancer,LETROZOLE tablet,"50268-476-11, 50268-476-15",,,,,,
718,*,Letrozole,Breast cancer,LETROZOLE tablet,"50268-476-11, 50268-476-15",,,Yes,,,Yes
719,hormone receptor positive early breast cancer,Letrozole,Breast cancer,LETROZOLE tablet,"71335-1526-1, 71335-1526-2, 71335-1526-3",,,,,,
720,*,Letrozole,Breast cancer,LETROZOLE tablet,"71335-1526-1, 71335-1526-2, 71335-1526-3",,,,,,
721,*,Letrozole,Breast cancer,LETROZOLE tablet,"71335-1526-1, 71335-1526-2, 71335-1526-3",,,Yes,,,Yes
722,hormone receptor positive early breast cancer,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",50090-3474-0,,,,,,
723,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",50090-3474-0,,,,,,
724,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",50090-3474-0,,,,,,Yes
725,hormone receptor positive early breast cancer,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",17856-0032-1,,,,,,
726,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",17856-0032-1,,,,,,
727,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",17856-0032-1,,,,,,Yes
728,hormone receptor positive early breast cancer,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",42291-374-90,,,,,,
729,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",42291-374-90,,,,,,
730,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",42291-374-90,,,,,,Yes
731,hormone receptor positive early breast cancer,Letrozole,Breast cancer,"LETROZOLE tablet, film coated","63629-7819-1, 63629-7819-2, 63629-7819-4",,,,,,
732,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated","63629-7819-1, 63629-7819-2, 63629-7819-4",,,,,,
733,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated","63629-7819-1, 63629-7819-2, 63629-7819-4",,,,,,Yes
734,hormone receptor positive early breast cancer,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",68071-5264-3,,,,,,
735,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",68071-5264-3,,,,,,
736,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",68071-5264-3,,,,,,Yes
737,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",54868-6252-0,,,,,,
738,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",54868-6252-0,,,,,,Yes
739,hormone receptor positive early breast cancer,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",42254-243-30,,,,,,
740,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",42254-243-30,,,,,,
741,*,Letrozole,Breast cancer,"LETROZOLE tablet, film coated",42254-243-30,,,,,,Yes
742,anti-HER2,Pertuzumab,Breast cancer,"PERJETA- pertuzumab injection, solution, concentrate",50242-145-01,"trastuzumab, docetaxel",anti-HER2,,,,Yes
743,*,Pertuzumab,Breast cancer,"PERJETA- pertuzumab injection, solution, concentrate",50242-145-01,trastuzumab,,,,,
744,*,Pertuzumab,Breast cancer,"PERJETA- pertuzumab injection, solution, concentrate",50242-145-01,,,,,,
745,*,Ado-Trastuzumab Emtansine,Breast cancer,"KADCYLA- ado-trastuzumab emtansine injection, powder, lyophilized, for solution","50242-087-01, 50242-088-01",,,,,,Yes
746,*,Ado-Trastuzumab Emtansine,Breast cancer,"KADCYLA- ado-trastuzumab emtansine injection, powder, lyophilized, for solution","50242-087-01, 50242-088-01",,,,,,
747,*,Palbociclib,Breast cancer,PALBOCICLIB powder,73309-167-01,,,,,,
748,aromatase,Palbociclib,Breast cancer,IBRANCE- palbociclib capsule,"0069-0187-21, 0069-0188-21, 0069-0189-21",,,,,,Yes
749,hormone receptor (HR)-positive,Palbociclib,Breast cancer,IBRANCE- palbociclib capsule,"0069-0187-21, 0069-0188-21, 0069-0189-21",,,,,,Yes
750,human epidermal growth factor receptor 2,Palbociclib,Breast cancer,IBRANCE- palbociclib capsule,"0069-0187-21, 0069-0188-21, 0069-0189-21",,,,,,Yes
751,hormone receptor,Palbociclib,Breast cancer,IBRANCE- palbociclib capsule,"0069-0187-21, 0069-0188-21, 0069-0189-21",,,,,,Yes
752,*,Palbociclib,Breast cancer,IBRANCE- palbociclib capsule,"63539-187-11, 63539-188-11, 63539-189-11",,,,Yes,,Yes
753,*,Palbociclib,Breast cancer,IBRANCE- palbociclib capsule,"63539-187-11, 63539-188-11, 63539-189-11",letrozole,,,Yes,,
754,*,Palbociclib,Breast cancer,IBRANCE- palbociclib capsule,"63539-187-11, 63539-188-11, 63539-189-11",,,,Yes,,
755,aromatase,Palbociclib,Breast cancer,"IBRANCE- palbociclib tablet, film coated","0069-0284-03, 0069-0284-07, 0069-0486-03, 0069-0486-07, 0069-0688-03, 0069-0688-07",,,,,,Yes
756,hormone receptor (HR)-positive,Palbociclib,Breast cancer,"IBRANCE- palbociclib tablet, film coated","0069-0284-03, 0069-0284-07, 0069-0486-03, 0069-0486-07, 0069-0688-03, 0069-0688-07",,,,,,Yes
757,human epidermal growth factor receptor 2,Palbociclib,Breast cancer,"IBRANCE- palbociclib tablet, film coated","0069-0284-03, 0069-0284-07, 0069-0486-03, 0069-0486-07, 0069-0688-03, 0069-0688-07",,,,,,Yes
758,hormone receptor,Palbociclib,Breast cancer,"IBRANCE- palbociclib tablet, film coated","0069-0284-03, 0069-0284-07, 0069-0486-03, 0069-0486-07, 0069-0688-03, 0069-0688-07",,,,,,Yes
759,aromatase,Palbociclib,Breast cancer,"IBRANCE- palbociclib tablet, film coated","63539-284-03, 63539-284-07, 63539-486-03, 63539-486-07, 63539-688-03, 63539-688-07",,,,,,Yes
760,hormone receptor (HR)-positive,Palbociclib,Breast cancer,"IBRANCE- palbociclib tablet, film coated","63539-284-03, 63539-284-07, 63539-486-03, 63539-486-07, 63539-688-03, 63539-688-07",,,,,,Yes
761,human epidermal growth factor receptor 2,Palbociclib,Breast cancer,"IBRANCE- palbociclib tablet, film coated","63539-284-03, 63539-284-07, 63539-486-03, 63539-486-07, 63539-688-03, 63539-688-07",,,,,,Yes
762,hormone receptor,Palbociclib,Breast cancer,"IBRANCE- palbociclib tablet, film coated","63539-284-03, 63539-284-07, 63539-486-03, 63539-486-07, 63539-688-03, 63539-688-07",,,,,,Yes
763,aromatase,Ribociclib,Breast cancer,"KISQALI- ribociclib tablet, film coated","0078-0860-01, 0078-0867-14, 0078-0867-42, 0078-0874-21, 0078-0874-63",fulvestrant,,,,,Yes
764,hormone receptor (HR)-positive,Ribociclib,Breast cancer,"KISQALI- ribociclib tablet, film coated","0078-0860-01, 0078-0867-14, 0078-0867-42, 0078-0874-21, 0078-0874-63",fulvestrant,,,,,Yes
765,human epidermal growth factor receptor 2,Ribociclib,Breast cancer,"KISQALI- ribociclib tablet, film coated","0078-0860-01, 0078-0867-14, 0078-0867-42, 0078-0874-21, 0078-0874-63",fulvestrant,,,,,Yes
766,human epidermal growth factor receptor 2,Neratinib Maleate,Breast cancer,NERLYNX- neratinib tablet,"70437-240-18, 70437-240-26, 70437-240-33",,,,,,
767,anti-HER2,Neratinib Maleate,Breast cancer,NERLYNX- neratinib tablet,"70437-240-18, 70437-240-26, 70437-240-33",capecitabine,,,,,Yes
768,anti-HER2,Neratinib Maleate,Breast cancer,NERLYNX- neratinib tablet,"70437-240-18, 70437-240-26, 70437-240-33",capecitabine,,,,,
769,aromatase,Abemaciclib,Breast cancer,VERZENIO- abemaciclib tablet,"0002-4483-54, 0002-4815-54, 0002-5337-54, 0002-5337-63, 0002-6216-54",,,,,,Yes
770,hormone receptor (HR)-positive,Abemaciclib,Breast cancer,VERZENIO- abemaciclib tablet,"0002-4483-54, 0002-4815-54, 0002-5337-54, 0002-5337-63, 0002-6216-54",,,,,,Yes
771,human epidermal growth factor receptor 2,Abemaciclib,Breast cancer,VERZENIO- abemaciclib tablet,"0002-4483-54, 0002-4815-54, 0002-5337-54, 0002-5337-63, 0002-6216-54",,,,,,Yes
772,hormone receptor (HR)-positive,Abemaciclib,Breast cancer,VERZENIO- abemaciclib tablet,"0002-4483-54, 0002-4815-54, 0002-5337-54, 0002-5337-63, 0002-6216-54",fulvestrant,,,,,Yes
773,human epidermal growth factor receptor 2,Abemaciclib,Breast cancer,VERZENIO- abemaciclib tablet,"0002-4483-54, 0002-4815-54, 0002-5337-54, 0002-5337-63, 0002-6216-54",fulvestrant,,,,,Yes
774,*,Abemaciclib,Breast cancer,VERZENIO- abemaciclib tablet,"0002-4483-54, 0002-4815-54, 0002-5337-54, 0002-5337-63, 0002-6216-54",,,,,,Yes
775,*,Olaparib,primary peritoneal cancer,OLAPARIB powder,"73309-165-01, 73309-165-02",,,,,,
776,*,Olaparib,Prostate cancer,OLAPARIB powder,"73309-165-01, 73309-165-02",,,,,,
777,*,Olaparib,Pancreatic cancer,OLAPARIB powder,"73309-165-01, 73309-165-02",,,,,,
778,*,Olaparib,Breast cancer,OLAPARIB powder,"73309-165-01, 73309-165-02",,,,,,
779,*,Olaparib,fallopian tube,OLAPARIB powder,"73309-165-01, 73309-165-02",,,,,,
780,*,Olaparib,Ovarian cancer,OLAPARIB powder,"73309-165-01, 73309-165-02",,,,,,
781,*,Olaparib,Ovarian epithelial,OLAPARIB powder,"73309-165-01, 73309-165-02",,,,,,
782,*,Olaparib,primary peritoneal cancer,"LYNPARZA- olaparib tablet, film coated","0310-0668-12, 0310-0668-60, 0310-0679-12, 0310-0679-60, 0310-0679-95",,,,,,
783,BRCA mutation,Olaparib,primary peritoneal cancer,"LYNPARZA- olaparib tablet, film coated","0310-0668-12, 0310-0668-60, 0310-0679-12, 0310-0679-60, 0310-0679-95",bevacizumab,,,,,
784,gBRCAm,Olaparib,primary peritoneal cancer,"LYNPARZA- olaparib tablet, film coated","0310-0668-12, 0310-0668-60, 0310-0679-12, 0310-0679-60, 0310-0679-95",,,,,,
785,hormone receptor,Olaparib,primary peritoneal cancer,"LYNPARZA- olaparib tablet, film coated","0310-0668-12, 0310-0668-60, 0310-0679-12, 0310-0679-60, 0310-0679-95",,,,,,
786,*,Olaparib,Prostate cancer,"LYNPARZA- olaparib tablet, film coated","0310-0668-12, 0310-0668-60, 0310-0679-12, 0310-0679-60, 0310-0679-95",,,,,,
787,*,Olaparib,Pancreatic cancer,"LYNPARZA- olaparib tablet, film coated","0310-0668-12, 0310-0668-60, 0310-0679-12, 0310-0679-60, 0310-0679-95",,,,,,
788,gBRCAm,Olaparib,Breast cancer,"LYNPARZA- olaparib tablet, film coated","0310-0668-12, 0310-0668-60, 0310-0679-12, 0310-0679-60, 0310-0679-95",,,,,,Yes
789,hormone receptor,Olaparib,Breast cancer,"LYNPARZA- olaparib tablet, film coated","0310-0668-12, 0310-0668-60, 0310-0679-12, 0310-0679-60, 0310-0679-95",,,,,,
790,*,Olaparib,Breast cancer,"LYNPARZA- olaparib tablet, film coated","0310-0668-12, 0310-0668-60, 0310-0679-12, 0310-0679-60, 0310-0679-95",,,,,,
791,*,Olaparib,fallopian tube,"LYNPARZA- olaparib tablet, film coated","0310-0668-12, 0310-0668-60, 0310-0679-12, 0310-0679-60, 0310-0679-95",,,,,,
792,BRCA mutation,Olaparib,fallopian tube,"LYNPARZA- olaparib tablet, film coated","0310-0668-12, 0310-0668-60, 0310-0679-12, 0310-0679-60, 0310-0679-95",bevacizumab,,,,,
793,gBRCAm,Olaparib,fallopian tube,"LYNPARZA- olaparib tablet, film coated","0310-0668-12, 0310-0668-60, 0310-0679-12, 0310-0679-60, 0310-0679-95",,,,,,
794,hormone receptor,Olaparib,fallopian tube,"LYNPARZA- olaparib tablet, film coated","0310-0668-12, 0310-0668-60, 0310-0679-12, 0310-0679-60, 0310-0679-95",,,,,,
795,BRCA mutation,Olaparib,Ovarian cancer,"LYNPARZA- olaparib tablet, film coated","0310-0668-12, 0310-0668-60, 0310-0679-12, 0310-0679-60, 0310-0679-95",bevacizumab,,,,,
796,*,Olaparib,Ovarian cancer,"LYNPARZA- olaparib tablet, film coated","0310-0668-12, 0310-0668-60, 0310-0679-12, 0310-0679-60, 0310-0679-95",,,,,,
797,*,Olaparib,Ovarian epithelial,"LYNPARZA- olaparib tablet, film coated","0310-0668-12, 0310-0668-60, 0310-0679-12, 0310-0679-60, 0310-0679-95",,,,,,
798,human epidermal growth factor receptor 2,Talazoparib Tosylate,Breast cancer,TALZENNA- talazoparib capsule,"0069-0296-30, 0069-1195-30",,,,,,Yes
799,*,Talazoparib Tosylate,Breast cancer,TALZENNA- talazoparib capsule,"0069-0296-30, 0069-1195-30",,,,,,
800,hormone receptor (HR)-positive,Alpelisib,Breast cancer,PIQRAY- alpelisib tablet,"0078-0701-51, 0078-0701-84, 0078-0708-02, 0078-0708-51, 0078-0708-90, 0078-0708-91, 0078-0715-02, 0078-0715-61, 0078-0715-91, 0078-0715-94",fulvestrant,,,,,Yes
801,human epidermal growth factor receptor 2,Alpelisib,Breast cancer,PIQRAY- alpelisib tablet,"0078-0701-51, 0078-0701-84, 0078-0708-02, 0078-0708-51, 0078-0708-90, 0078-0708-91, 0078-0715-02, 0078-0715-61, 0078-0715-91, 0078-0715-94",fulvestrant,,,,,Yes
802,*,Fam-Trastuzumab Deruxtecan-nxki,Breast cancer,"ENHERTU- fam-trastuzumab deruxtecan-nxki injection, powder, lyophilized, for solution",65597-406-01,,,,Yes,Yes,
803,*,Fam-Trastuzumab Deruxtecan-nxki,Gastric (stomach) cancer,"ENHERTU- fam-trastuzumab deruxtecan-nxki injection, powder, lyophilized, for solution",65597-406-01,,,,,,
804,*,Fam-Trastuzumab Deruxtecan-nxki,gastroesophageal junction cancer,"ENHERTU- fam-trastuzumab deruxtecan-nxki injection, powder, lyophilized, for solution",65597-406-01,,,,,,
805,*,Tucatinib,Breast cancer,TUKYSA- tucatinib tablet,"51144-001-60, 51144-002-12, 51144-002-60","trastuzumab, capecitabine",,,,,
806,*,"Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf",Breast cancer,"PHESGO- pertuzumab, trastuzumab, and hyaluronidase-zzxf injection, solution","50242-245-01, 50242-245-86, 50242-260-01, 50242-260-86",,,,,,
807,anti-HER2,"Pertuzumab, Trastuzumab, and Hyaluronidase-zzxf",Breast cancer,"PHESGO- pertuzumab, trastuzumab, and hyaluronidase-zzxf injection, solution","50242-245-01, 50242-245-86, 50242-260-01, 50242-260-86",docetaxel,anti-HER2,,,,Yes
808,*,Margetuximab-cmkb,Breast cancer,"MARGENZA- margetuximab-cmkb injection, solution, concentrate","74527-022-01, 74527-022-02, 74527-022-03",,,,,,
809,K-Ras wild-type,Cetuximab,Colorectal cancer,ERBITUX- cetuximab solution,"66733-948-23, 66733-958-23","FOLFIRI, fluorouracil, irinotecan, leucovorin",,Yes,,,Yes
810,epidermal growth factor receptor,Cetuximab,Colorectal cancer,ERBITUX- cetuximab solution,"66733-948-23, 66733-958-23","FOLFIRI, fluorouracil, irinotecan, leucovorin",,Yes,,,Yes
811,K-Ras,Cetuximab,Colorectal cancer,ERBITUX- cetuximab solution,"66733-948-23, 66733-958-23","FOLFIRI, fluorouracil, irinotecan, leucovorin",,Yes,,,Yes
812,Ras,Cetuximab,Colorectal cancer,ERBITUX- cetuximab solution,"66733-948-23, 66733-958-23",,,,,,
813,SCCHN,Cetuximab,Squamous cell carcinoma of the head and neck,ERBITUX- cetuximab solution,"66733-948-23, 66733-958-23",,,,,,
814,SCCHN,Cetuximab,Squamous cell carcinoma of the head and neck,ERBITUX- cetuximab solution,"66733-948-23, 66733-958-23",fluorouracil,,,,,
815,*,Cetuximab,Squamous cell carcinoma of the head and neck,ERBITUX- cetuximab solution,"66733-948-23, 66733-958-23",,,,,,
816,wild-type RAS,Panitumumab,Colorectal cancer,VECTIBIX- panitumumab solution,"55513-954-01, 55513-956-01",FOLFOX,,,,,Yes
817,NRAS,Panitumumab,Colorectal cancer,VECTIBIX- panitumumab solution,"55513-954-01, 55513-956-01",FOLFOX,,,,,Yes
818,KRAS,Panitumumab,Colorectal cancer,VECTIBIX- panitumumab solution,"55513-954-01, 55513-956-01",FOLFOX,,,,,Yes
819,•,Panitumumab,Colorectal cancer,VECTIBIX- panitumumab solution,"55513-954-01, 55513-956-01",,,,,,
820,*,Panitumumab,Colorectal cancer,VECTIBIX- panitumumab solution,"55513-954-01, 55513-956-01",,,,,,
821,leucovorin,Ziv-Aflibercept,Colorectal cancer,"ZALTRAP- ziv-aflibercept solution, concentrate","0024-5840-01, 0024-5840-03, 0024-5841-01","fluorouracil, leucovorin",,,,,Yes
822,*,Regorafenib,Hepatocellular carcinoma,"STIVARGA- regorafenib tablet, film coated","50419-171-00, 50419-171-01, 50419-171-03, 50419-171-04, 50419-171-05, 50419-171-06",,,,,,
823,anti-EGFR,Regorafenib,Colorectal cancer,"STIVARGA- regorafenib tablet, film coated","50419-171-00, 50419-171-01, 50419-171-03, 50419-171-04, 50419-171-05, 50419-171-06",,,,,,Yes
824,sunitinib malate,Regorafenib,Gastrointestinal stromal tumor,"STIVARGA- regorafenib tablet, film coated","50419-171-00, 50419-171-01, 50419-171-03, 50419-171-04, 50419-171-05, 50419-171-06",,,,,,Yes
825,imatinib mesylate,Regorafenib,Gastrointestinal stromal tumor,"STIVARGA- regorafenib tablet, film coated","50419-171-00, 50419-171-01, 50419-171-03, 50419-171-04, 50419-171-05, 50419-171-06",,,,,,Yes
826,*,Ramucirumab,gastroesophageal junction adenocarcinoma,CYRAMZA- ramucirumab solution,"0002-7669-01, 0002-7678-01",,,,,,
827,*,Ramucirumab,Stomach adenocarcinoma,CYRAMZA- ramucirumab solution,"0002-7669-01, 0002-7678-01",,,,,,
828,epidermal growth factor receptor (EGFR) exon 19 deletions,Ramucirumab,Non-small cell lung cancer,CYRAMZA- ramucirumab solution,"0002-7669-01, 0002-7678-01",erlotinib,,Yes,,,Yes
829,epidermal growth factor receptor,Ramucirumab,Non-small cell lung cancer,CYRAMZA- ramucirumab solution,"0002-7669-01, 0002-7678-01",erlotinib,,Yes,,,Yes
830,EGFR,Ramucirumab,Non-small cell lung cancer,CYRAMZA- ramucirumab solution,"0002-7669-01, 0002-7678-01",erlotinib,,Yes,,,Yes
831,L858R,Ramucirumab,Non-small cell lung cancer,CYRAMZA- ramucirumab solution,"0002-7669-01, 0002-7678-01",erlotinib,,Yes,,,Yes
832,*,Ramucirumab,Non-small cell lung cancer,CYRAMZA- ramucirumab solution,"0002-7669-01, 0002-7678-01",docetaxel,,,,,Yes
833,anaplastic lymphoma kinase (ALK),Ramucirumab,Non-small cell lung cancer,CYRAMZA- ramucirumab solution,"0002-7669-01, 0002-7678-01",,,,,,
834,EGFR,Ramucirumab,Non-small cell lung cancer,CYRAMZA- ramucirumab solution,"0002-7669-01, 0002-7678-01",,,,,,
835,anaplastic lymphoma kinase,Ramucirumab,Non-small cell lung cancer,CYRAMZA- ramucirumab solution,"0002-7669-01, 0002-7678-01",,,,,,
836,epidermal growth factor receptor,Ramucirumab,Non-small cell lung cancer,CYRAMZA- ramucirumab solution,"0002-7669-01, 0002-7678-01",,,,,,
837,ALK,Ramucirumab,Non-small cell lung cancer,CYRAMZA- ramucirumab solution,"0002-7669-01, 0002-7678-01",,,,,,
838,ng/mL,Ramucirumab,Hepatocellular carcinoma,CYRAMZA- ramucirumab solution,"0002-7669-01, 0002-7678-01",,,,,,
839,AFP,Ramucirumab,Hepatocellular carcinoma,CYRAMZA- ramucirumab solution,"0002-7669-01, 0002-7678-01",,,,,,
840,alpha fetoprotein,Ramucirumab,Hepatocellular carcinoma,CYRAMZA- ramucirumab solution,"0002-7669-01, 0002-7678-01",,,,,,
841,*,Ramucirumab,Colorectal cancer,CYRAMZA- ramucirumab solution,"0002-7669-01, 0002-7678-01","FOLFIRI, folinic acid, fluorouracil, irinotecan",,,,,Yes
842,*,Ipilimumab,Malignant pleural mesothelioma,YERVOY- ipilimumab injection,"0003-2327-11, 0003-2328-22",nivolumab,,Yes,,,Yes
843,*,Ipilimumab,Renal cell carcinoma,YERVOY- ipilimumab injection,"0003-2327-11, 0003-2328-22",nivolumab,,Yes,,,
844,*,Ipilimumab,Melanoma,YERVOY- ipilimumab injection,"0003-2327-11, 0003-2328-22",,,,,,Yes
845,*,Ipilimumab,Melanoma,YERVOY- ipilimumab injection,"0003-2327-11, 0003-2328-22",nivolumab,,,,,Yes
846,*,Ipilimumab,Melanoma,YERVOY- ipilimumab injection,"0003-2327-11, 0003-2328-22",,,,,,
847,PD-L1,Ipilimumab,Non-small cell lung cancer,YERVOY- ipilimumab injection,"0003-2327-11, 0003-2328-22",nivolumab,"EGFR, ALK genomic",Yes,,,Yes
848,≥1,Ipilimumab,Non-small cell lung cancer,YERVOY- ipilimumab injection,"0003-2327-11, 0003-2328-22",nivolumab,"EGFR, ALK genomic",Yes,,,Yes
849,EGFR,Ipilimumab,Non-small cell lung cancer,YERVOY- ipilimumab injection,"0003-2327-11, 0003-2328-22",nivolumab,"EGFR, ALK genomic",Yes,,,Yes
850,ALK genomic,Ipilimumab,Non-small cell lung cancer,YERVOY- ipilimumab injection,"0003-2327-11, 0003-2328-22",nivolumab,"EGFR, ALK genomic",Yes,,,Yes
851,EGFR,Ipilimumab,Non-small cell lung cancer,YERVOY- ipilimumab injection,"0003-2327-11, 0003-2328-22",nivolumab,"EGFR, ALK genomic",,,,
852,ALK genomic,Ipilimumab,Non-small cell lung cancer,YERVOY- ipilimumab injection,"0003-2327-11, 0003-2328-22",nivolumab,"EGFR, ALK genomic",,,,
853,*,Ipilimumab,Hepatocellular carcinoma,YERVOY- ipilimumab injection,"0003-2327-11, 0003-2328-22",nivolumab,,,Yes,Yes,
854,*,Ipilimumab,Hepatocellular carcinoma,YERVOY- ipilimumab injection,"0003-2327-11, 0003-2328-22",,,,Yes,Yes,
855,MSI-H,Ipilimumab,Colorectal cancer,YERVOY- ipilimumab injection,"0003-2327-11, 0003-2328-22",nivolumab,,,Yes,Yes,Yes
856,*,Ipilimumab,Colorectal cancer,YERVOY- ipilimumab injection,"0003-2327-11, 0003-2328-22",,,,Yes,Yes,
857,BRAF,Encorafenib,Colorectal cancer,BRAFTOVI- encorafenib capsule,"70255-025-01, 70255-025-02, 70255-025-03, 70255-025-04, 70255-025-05, 70255-025-06",cetuximab,,,,,Yes
858,BRAF V600E,Encorafenib,Melanoma,BRAFTOVI- encorafenib capsule,"70255-025-01, 70255-025-02, 70255-025-03, 70255-025-04, 70255-025-05, 70255-025-06","BRAF V600E, binimetinib",,,,,Yes
859,*,Imatinib Mesylate,Chronic myelogenous leukemia,GLEEVEC- imatinib mesylate tablet,"0078-0401-34, 0078-0649-30",,,,,,
860,CHIC2 allele deletion,Imatinib Mesylate,hypereosinophilic syndrome,GLEEVEC- imatinib mesylate tablet,"0078-0401-34, 0078-0649-30",,,,,,
861,FIP1L1-PDGFRα fusion kinase,Imatinib Mesylate,hypereosinophilic syndrome,GLEEVEC- imatinib mesylate tablet,"0078-0401-34, 0078-0649-30",,,,,,
862,*,Imatinib Mesylate,Acute lymphoblastic leukemia,GLEEVEC- imatinib mesylate tablet,"0078-0401-34, 0078-0649-30",,,,,,
863,CHIC2 allele deletion,Imatinib Mesylate,Chronic eosinophilic leukemia,GLEEVEC- imatinib mesylate tablet,"0078-0401-34, 0078-0649-30",,,,,,
864,FIP1L1-PDGFRα fusion kinase,Imatinib Mesylate,Chronic eosinophilic leukemia,GLEEVEC- imatinib mesylate tablet,"0078-0401-34, 0078-0649-30",,,,,,
865,c-Kit,Imatinib Mesylate,Systemic mastocytosis,GLEEVEC- imatinib mesylate tablet,"0078-0401-34, 0078-0649-30",,"D816V c-Kit mutation, D816V c-Kit",,,,
866,D816V c-Kit mutation,Imatinib Mesylate,Systemic mastocytosis,GLEEVEC- imatinib mesylate tablet,"0078-0401-34, 0078-0649-30",,"D816V c-Kit mutation, D816V c-Kit",,,,
867,D816V c-Kit,Imatinib Mesylate,Systemic mastocytosis,GLEEVEC- imatinib mesylate tablet,"0078-0401-34, 0078-0649-30",,"D816V c-Kit mutation, D816V c-Kit",,,,
868,CD117,Imatinib Mesylate,Gastrointestinal stromal tumor,GLEEVEC- imatinib mesylate tablet,"0078-0401-34, 0078-0649-30",,,,,,
869,*,Imatinib Mesylate,Dermatofibrosarcoma protuberans,GLEEVEC- imatinib mesylate tablet,"0078-0401-34, 0078-0649-30",,,,,,Yes
870,*,Imatinib Mesylate,Myelodysplastic/myeloproliferative neoplasms,GLEEVEC- imatinib mesylate tablet,"0078-0401-34, 0078-0649-30",,,,,,
871,somatostatin,Lutetium Lu 177-Dotatate,Gastroenteropancreatic neuroendocrine tumors,LUTATHERA- lutetium lu 177 dotatate injection,69488-003-01,,,,,,
872,*,Iobenguane I 131,Pheochromocytoma,"AZEDRA- iobenguane i-131 injection, solution","71258-015-02, 71258-015-22",,,,,,Yes
873,*,Iobenguane I 131,paraganglioma,"AZEDRA- iobenguane i-131 injection, solution","71258-015-02, 71258-015-22",,,,,,
874,*,Lenvatinib Mesylate,Endometrial carcinoma,LENVIMA- lenvatinib capsule,"62856-704-05, 62856-704-30, 62856-708-05, 62856-708-30, 62856-710-05, 62856-710-30, 62856-712-05, 62856-712-30, 62856-714-05, 62856-714-30, 62856-718-05, 62856-718-30, 62856-720-05, 62856-720-30, 62856-724-05, 62856-724-30",,,,Yes,Yes,
875,*,Lenvatinib Mesylate,Endometrial carcinoma,LENVIMA- lenvatinib capsule,"62856-704-05, 62856-704-30, 62856-708-05, 62856-708-30, 62856-710-05, 62856-710-30, 62856-712-05, 62856-712-30, 62856-714-05, 62856-714-30, 62856-718-05, 62856-718-30, 62856-720-05, 62856-720-30, 62856-724-05, 62856-724-30",everolimus,,,Yes,Yes,
876,*,Lenvatinib Mesylate,Endometrial carcinoma,LENVIMA- lenvatinib capsule,"62856-704-05, 62856-704-30, 62856-708-05, 62856-708-30, 62856-710-05, 62856-710-30, 62856-712-05, 62856-712-30, 62856-714-05, 62856-714-30, 62856-718-05, 62856-718-30, 62856-720-05, 62856-720-30, 62856-724-05, 62856-724-30",,MSI-H,,Yes,Yes,
877,*,Lenvatinib Mesylate,Hepatocellular carcinoma,LENVIMA- lenvatinib capsule,"62856-704-05, 62856-704-30, 62856-708-05, 62856-708-30, 62856-710-05, 62856-710-30, 62856-712-05, 62856-712-30, 62856-714-05, 62856-714-30, 62856-718-05, 62856-718-30, 62856-720-05, 62856-720-30, 62856-724-05, 62856-724-30",,,,Yes,Yes,
878,*,Lenvatinib Mesylate,Hepatocellular carcinoma,LENVIMA- lenvatinib capsule,"62856-704-05, 62856-704-30, 62856-708-05, 62856-708-30, 62856-710-05, 62856-710-30, 62856-712-05, 62856-712-30, 62856-714-05, 62856-714-30, 62856-718-05, 62856-718-30, 62856-720-05, 62856-720-30, 62856-724-05, 62856-724-30",everolimus,,,Yes,Yes,
879,*,Lenvatinib Mesylate,Hepatocellular carcinoma,LENVIMA- lenvatinib capsule,"62856-704-05, 62856-704-30, 62856-708-05, 62856-708-30, 62856-710-05, 62856-710-30, 62856-712-05, 62856-712-30, 62856-714-05, 62856-714-30, 62856-718-05, 62856-718-30, 62856-720-05, 62856-720-30, 62856-724-05, 62856-724-30",,,Yes,Yes,Yes,
880,*,Lenvatinib Mesylate,Hepatocellular carcinoma,LENVIMA- lenvatinib capsule,"62856-704-05, 62856-704-30, 62856-708-05, 62856-708-30, 62856-710-05, 62856-710-30, 62856-712-05, 62856-712-30, 62856-714-05, 62856-714-30, 62856-718-05, 62856-718-30, 62856-720-05, 62856-720-30, 62856-724-05, 62856-724-30",,MSI-H,,Yes,Yes,
881,*,Lenvatinib Mesylate,Renal cell carcinoma,LENVIMA- lenvatinib capsule,"62856-704-05, 62856-704-30, 62856-708-05, 62856-708-30, 62856-710-05, 62856-710-30, 62856-712-05, 62856-712-30, 62856-714-05, 62856-714-30, 62856-718-05, 62856-718-30, 62856-720-05, 62856-720-30, 62856-724-05, 62856-724-30",,,,Yes,Yes,
882,*,Lenvatinib Mesylate,Renal cell carcinoma,LENVIMA- lenvatinib capsule,"62856-704-05, 62856-704-30, 62856-708-05, 62856-708-30, 62856-710-05, 62856-710-30, 62856-712-05, 62856-712-30, 62856-714-05, 62856-714-30, 62856-718-05, 62856-718-30, 62856-720-05, 62856-720-30, 62856-724-05, 62856-724-30",everolimus,,,Yes,Yes,
883,*,Lenvatinib Mesylate,Renal cell carcinoma,LENVIMA- lenvatinib capsule,"62856-704-05, 62856-704-30, 62856-708-05, 62856-708-30, 62856-710-05, 62856-710-30, 62856-712-05, 62856-712-30, 62856-714-05, 62856-714-30, 62856-718-05, 62856-718-30, 62856-720-05, 62856-720-30, 62856-724-05, 62856-724-30",,MSI-H,,Yes,Yes,
884,*,Lenvatinib Mesylate,Thyroid cancer,LENVIMA- lenvatinib capsule,"62856-704-05, 62856-704-30, 62856-708-05, 62856-708-30, 62856-710-05, 62856-710-30, 62856-712-05, 62856-712-30, 62856-714-05, 62856-714-30, 62856-718-05, 62856-718-30, 62856-720-05, 62856-720-30, 62856-724-05, 62856-724-30",,,,Yes,Yes,
885,*,Lenvatinib Mesylate,Thyroid cancer,LENVIMA- lenvatinib capsule,"62856-704-05, 62856-704-30, 62856-708-05, 62856-708-30, 62856-710-05, 62856-710-30, 62856-712-05, 62856-712-30, 62856-714-05, 62856-714-30, 62856-718-05, 62856-718-30, 62856-720-05, 62856-720-30, 62856-724-05, 62856-724-30",everolimus,,,Yes,Yes,
886,*,Lenvatinib Mesylate,Thyroid cancer,LENVIMA- lenvatinib capsule,"62856-704-05, 62856-704-30, 62856-708-05, 62856-708-30, 62856-710-05, 62856-710-30, 62856-712-05, 62856-712-30, 62856-714-05, 62856-714-30, 62856-718-05, 62856-718-30, 62856-720-05, 62856-720-30, 62856-724-05, 62856-724-30",,MSI-H,,Yes,Yes,
887,*,Dostarlimab-gxly,Endometrial cancer,JEMPERLI- dostarlimab injection,0173-0898-03,,,,Yes,Yes,
888,*,Sunitinib Malate,Renal cell carcinoma,SUTENT- sunitinib malate capsule,"0069-0550-38, 0069-0770-38, 0069-0830-38, 0069-0980-38",,,,,,
889,*,Sunitinib Malate,Pancreatic cancer,SUTENT- sunitinib malate capsule,"0069-0550-38, 0069-0770-38, 0069-0830-38, 0069-0980-38",,,,,,
890,imatinib mesylate,Sunitinib Malate,Gastrointestinal stromal tumor,SUTENT- sunitinib malate capsule,"0069-0550-38, 0069-0770-38, 0069-0830-38, 0069-0980-38",,,,,,
891,*,Avapritinib,Systemic mastocytosis,"AYVAKIT- avapritinib tablet, film coated","72064-110-30, 72064-120-30, 72064-125-30, 72064-130-30, 72064-150-30",,,,,,
892,SM-AHN,Avapritinib,Systemic mastocytosis,"AYVAKIT- avapritinib tablet, film coated","72064-110-30, 72064-120-30, 72064-125-30, 72064-130-30, 72064-150-30",,,,,,
893,PDGFRA D842V mutations,Avapritinib,Gastrointestinal stromal tumor,"AYVAKIT- avapritinib tablet, film coated","72064-110-30, 72064-120-30, 72064-125-30, 72064-130-30, 72064-150-30",,,,,,
894,platelet-derived growth factor receptor alpha (PDGFRA) exon 18,Avapritinib,Gastrointestinal stromal tumor,"AYVAKIT- avapritinib tablet, film coated","72064-110-30, 72064-120-30, 72064-125-30, 72064-130-30, 72064-150-30",,,,,,
895,PDGFRA,Avapritinib,Gastrointestinal stromal tumor,"AYVAKIT- avapritinib tablet, film coated","72064-110-30, 72064-120-30, 72064-125-30, 72064-130-30, 72064-150-30",,,,,,
896,platelet-derived growth factor receptor alpha,Avapritinib,Gastrointestinal stromal tumor,"AYVAKIT- avapritinib tablet, film coated","72064-110-30, 72064-120-30, 72064-125-30, 72064-130-30, 72064-150-30",,,,,,
897,*,Ripretinib,Gastrointestinal stromal tumor,QINLOCK- ripretinib tablet,"73207-101-30, 73207-101-31",,,,,,
898,*,Denosumab,Hypercalcemia of malignancy,PROLIA- denosumab injection,55513-710-01,,,,,,
899,*,Denosumab,Giant cell tumor of the bone,PROLIA- denosumab injection,55513-710-01,,,,,,
900,aromatase,Denosumab,Breast cancer,PROLIA- denosumab injection,55513-710-01,,,,,,
901,*,Denosumab,Broken bones and other bone problems,PROLIA- denosumab injection,55513-710-01,,,,,,
902,androgen,Denosumab,Prostate cancer,PROLIA- denosumab injection,55513-710-01,,,,,,Yes
903,*,Denosumab,Prostate cancer,PROLIA- denosumab injection,55513-710-01,,,,,,
904,*,Denosumab,Hypercalcemia of malignancy,XGEVA- denosumab injection,55513-730-01,,,,,,
905,*,Denosumab,Giant cell tumor of the bone,XGEVA- denosumab injection,55513-730-01,,,,,,
906,*,Denosumab,Breast cancer,XGEVA- denosumab injection,55513-730-01,,,,,,
907,*,Denosumab,Broken bones and other bone problems,XGEVA- denosumab injection,55513-730-01,,,,,,
908,*,Denosumab,Prostate cancer,XGEVA- denosumab injection,55513-730-01,,,,,,
909,*,Pexidartinib Hydrochloride,Tenosynovial giant cell tumor,TURALIO- pexidartinib capsule,"65597-402-20, 65597-402-28",,,,,,
910,*,Sorafenib Tosylate,Hepatocellular carcinoma,"NEXAVAR- sorafenib tablet, film coated",50419-488-58,,,,,,Yes
911,*,Sorafenib Tosylate,Renal cell carcinoma,"NEXAVAR- sorafenib tablet, film coated",50419-488-58,,,,,,
912,*,Sorafenib Tosylate,Thyroid cancer,"NEXAVAR- sorafenib tablet, film coated",50419-488-58,,,,,,
913,*,Pazopanib Hydrochloride,Renal cell carcinoma,"VOTRIENT- pazopanib hydrochloride tablet, film coated",0078-0670-66,,,,,,
914,*,Pazopanib Hydrochloride,Soft tissue sarcoma,"VOTRIENT- pazopanib hydrochloride tablet, film coated",0078-0670-66,,,,,,
915,*,Temsirolimus,Renal cell carcinoma,TORISEL- temsirolimus kit,"0008-1125-01, 0008-1179-01, 0008-1279-01",,,,,,
916,*,Axitinib,Renal cell carcinoma,"INLYTA- axitinib tablet, film coated","0069-0145-01, 0069-0151-11",,,Yes,,,
917,*,Axitinib,Renal cell carcinoma,"INLYTA- axitinib tablet, film coated","0069-0145-01, 0069-0151-11",,,,,,
918,*,Cabozantinib-S-Malate,Hepatocellular carcinoma,CABOMETYX- cabozantinib tablet,"42388-023-26, 42388-023-36, 42388-023-37, 42388-024-26, 42388-024-37, 42388-025-26, 42388-025-37",,,,,,
919,*,Cabozantinib-S-Malate,Renal cell carcinoma,CABOMETYX- cabozantinib tablet,"42388-023-26, 42388-023-36, 42388-023-37, 42388-024-26, 42388-024-37, 42388-025-26, 42388-025-37",,,,,,
920,*,Cabozantinib-S-Malate,Renal cell carcinoma,CABOMETYX- cabozantinib tablet,"42388-023-26, 42388-023-36, 42388-023-37, 42388-024-26, 42388-024-37, 42388-025-26, 42388-025-37",nivolumab,,,,,
921,*,Cabozantinib-S-Malate,Medullary thyroid cancer,CABOMETYX- cabozantinib tablet,"42388-023-26, 42388-023-36, 42388-023-37, 42388-024-26, 42388-024-37, 42388-025-26, 42388-025-37",,,,,,
922,*,Cabozantinib-S-Malate,Hepatocellular carcinoma,COMETRIQ- cabozantinib kit,"42388-011-14, 42388-012-14, 42388-013-14",,,,,,
923,*,Cabozantinib-S-Malate,Renal cell carcinoma,COMETRIQ- cabozantinib kit,"42388-011-14, 42388-012-14, 42388-013-14",,,,,,
924,*,Cabozantinib-S-Malate,Medullary thyroid cancer,COMETRIQ- cabozantinib kit,"42388-011-14, 42388-012-14, 42388-013-14",,,,,,Yes
925,*,Tivozanib Hydrochloride,Renal cell carcinoma,FOTIVDA- tivozanib capsule,"45629-089-01, 45629-134-01",,,,,,
926,myeloid leukemia,Dasatinib,Acute lymphoblastic leukemia,SPRYCEL- dasatinib tablet,"0003-0524-11, 0003-0527-11, 0003-0528-11, 0003-0852-22, 0003-0855-22, 0003-0857-22",,,,,,
927,*,Dasatinib,Acute lymphoblastic leukemia,SPRYCEL- dasatinib tablet,"0003-0524-11, 0003-0527-11, 0003-0528-11, 0003-0852-22, 0003-0855-22, 0003-0857-22",,,,,,
928,CML,Dasatinib,Acute lymphoblastic leukemia,SPRYCEL- dasatinib tablet,"0003-0524-11, 0003-0527-11, 0003-0528-11, 0003-0852-22, 0003-0855-22, 0003-0857-22",,,,,,
929,"•
",Dasatinib,Acute lymphoblastic leukemia,SPRYCEL- dasatinib tablet,"0003-0524-11, 0003-0527-11, 0003-0528-11, 0003-0852-22, 0003-0855-22, 0003-0857-22",,,,,,
930,*,Dasatinib,Chronic myelogenous leukemia,SPRYCEL- dasatinib tablet,"0003-0524-11, 0003-0527-11, 0003-0528-11, 0003-0852-22, 0003-0855-22, 0003-0857-22",,,,,,
931,*,Nilotinib,Chronic myelogenous leukemia,TASIGNA- nilotinib capsule,"0078-0526-51, 0078-0526-87, 0078-0592-51, 0078-0592-87, 0078-0951-66",,,,,,
932,TKI,Nilotinib,Chronic myelogenous leukemia,TASIGNA- nilotinib capsule,"0078-0526-51, 0078-0526-87, 0078-0592-51, 0078-0592-87, 0078-0951-66",,,,,,
933,tyrosine-kinase inhibitor,Nilotinib,Chronic myelogenous leukemia,TASIGNA- nilotinib capsule,"0078-0526-51, 0078-0526-87, 0078-0592-51, 0078-0592-87, 0078-0951-66",,,,,,
934,*,Bosutinib,Chronic myelogenous leukemia,"BOSULIF- bosutinib monohydrate tablet, film coated","0069-0135-01, 0069-0136-01, 0069-0193-01",,,,,,
935,*,Rituximab,B-cell non-Hodgkin lymphoma,"RITUXAN- rituximab injection, solution","50242-051-10, 50242-051-21, 50242-053-06",,,,,,
936,*,Rituximab,Chronic lymphocytic leukemia,"RITUXAN- rituximab injection, solution","50242-051-10, 50242-051-21, 50242-053-06","cyclophosphamide, fludarabine",,,,,
937,B-CLL,Alemtuzumab,B-cell chronic lymphocytic leukemia,CAMPATH- alemtuzumab injection,"58468-0357-1, 58468-0357-3",,,,,,
938,*,Ofatumumab,Chronic lymphocytic leukemia,"ARZERRA- ofatumumab injection, solution","0078-0669-13, 0078-0669-61, 0078-0690-61","cyclophosphamide, fludarabine, chlorambucil",,,,,
939,*,Obinutuzumab,Follicular lymphoma,"GAZYVA- obinutuzumab injection, solution, concentrate","50242-070-01, 50242-070-86",bendamustine,,,,,
940,*,Obinutuzumab,Follicular lymphoma,"GAZYVA- obinutuzumab injection, solution, concentrate","50242-070-01, 50242-070-86",,,,,,
941,*,Obinutuzumab,Chronic lymphocytic leukemia,"GAZYVA- obinutuzumab injection, solution, concentrate","50242-070-01, 50242-070-86",chlorambucil,,,,,
942,*,Ibrutinib,Mantle cell lymphoma,IMBRUVICA- ibrutinib capsule,"57962-014-28, 57962-070-28, 57962-140-09, 57962-140-12, 57962-280-28, 57962-420-28, 57962-420-71, 57962-560-28, 57962-560-71",,,,Yes,Yes,
943,*,Ibrutinib,small lymphocytic lymphoma,IMBRUVICA- ibrutinib capsule,"57962-014-28, 57962-070-28, 57962-140-09, 57962-140-12, 57962-280-28, 57962-420-28, 57962-420-71, 57962-560-28, 57962-560-71",,,,Yes,Yes,
944,*,Ibrutinib,Marginal zone lymphoma,IMBRUVICA- ibrutinib capsule,"57962-014-28, 57962-070-28, 57962-140-09, 57962-140-12, 57962-280-28, 57962-420-28, 57962-420-71, 57962-560-28, 57962-560-71",,,,Yes,Yes,
945,*,Ibrutinib,Chronic lymphocytic leukemia,IMBRUVICA- ibrutinib capsule,"57962-014-28, 57962-070-28, 57962-140-09, 57962-140-12, 57962-280-28, 57962-420-28, 57962-420-71, 57962-560-28, 57962-560-71",,,,Yes,Yes,
946,*,Ibrutinib,Waldenström macroglobulinemia,IMBRUVICA- ibrutinib capsule,"57962-014-28, 57962-070-28, 57962-140-09, 57962-140-12, 57962-280-28, 57962-420-28, 57962-420-71, 57962-560-28, 57962-560-71",,,,,,
947,*,Idelalisib,Non-Hodgkin lymphoma,"ZYDELIG- idelalisib tablet, film coated","61958-1701-1, 61958-1702-1",,,,Yes,Yes,
948,*,Idelalisib,Non-Hodgkin lymphoma,"ZYDELIG- idelalisib tablet, film coated","61958-1701-1, 61958-1702-1","bendamustine, FL, rituximab",,,Yes,Yes,
949,*,Idelalisib,Chronic lymphocytic leukemia,"ZYDELIG- idelalisib tablet, film coated","61958-1701-1, 61958-1702-1",rituximab,,,,,
950,*,Idelalisib,Chronic lymphocytic leukemia,"ZYDELIG- idelalisib tablet, film coated","61958-1701-1, 61958-1702-1",,,,,,
951,*,Blinatumomab,B-cell acute lymphoblastic leukemia,BLINCYTO- blinatumomab kit,"55513-150-01, 55513-155-01, 55513-160-01",,,,,,
952,*,Venetoclax,Acute myeloid leukemia,VENCLEXTA- venetoclax kit,"0074-0561-11, 0074-0561-14, 0074-0566-07, 0074-0566-11, 0074-0576-11, 0074-0576-22, 0074-0576-34, 0074-0579-28","low-dose cytarabine, azacitidine, decitabine",,,,,
953,*,Venetoclax,Chronic lymphocytic leukemia,VENCLEXTA- venetoclax kit,"0074-0561-11, 0074-0561-14, 0074-0566-07, 0074-0566-11, 0074-0576-11, 0074-0576-22, 0074-0576-34, 0074-0579-28",,,,,,
954,*,Venetoclax,small lymphocytic lymphoma,VENCLEXTA- venetoclax kit,"0074-0561-11, 0074-0561-14, 0074-0566-07, 0074-0566-11, 0074-0576-11, 0074-0576-22, 0074-0576-34, 0074-0579-28",,,,,,
955,FLT3,Midostaurin,Aggressive systemic mastocytosis,"RYDAPT capsule, liquid filled","0078-0698-02, 0078-0698-19, 0078-0698-51, 0078-0698-99","daunorubicin, cytarabine",,,,,
956,*,Midostaurin,Aggressive systemic mastocytosis,"RYDAPT capsule, liquid filled","0078-0698-02, 0078-0698-19, 0078-0698-51, 0078-0698-99",,Use RYDAPT,,,,
957,SM-AHN,Midostaurin,Aggressive systemic mastocytosis,"RYDAPT capsule, liquid filled","0078-0698-02, 0078-0698-19, 0078-0698-51, 0078-0698-99",,,,,,
958,FLT3,Midostaurin,Acute myeloid leukemia,"RYDAPT capsule, liquid filled","0078-0698-02, 0078-0698-19, 0078-0698-51, 0078-0698-99","daunorubicin, cytarabine",,,,,
959,*,Midostaurin,Acute myeloid leukemia,"RYDAPT capsule, liquid filled","0078-0698-02, 0078-0698-19, 0078-0698-51, 0078-0698-99",,Use RYDAPT,,,,
960,*,Midostaurin,systemic mastocytosis with associated hematologic neoplasm,"RYDAPT capsule, liquid filled","0078-0698-02, 0078-0698-19, 0078-0698-51, 0078-0698-99",,,,,,
961,FLT3,Midostaurin,mast cell leukemia,"RYDAPT capsule, liquid filled","0078-0698-02, 0078-0698-19, 0078-0698-51, 0078-0698-99","daunorubicin, cytarabine",,,,,
962,*,Midostaurin,mast cell leukemia,"RYDAPT capsule, liquid filled","0078-0698-02, 0078-0698-19, 0078-0698-51, 0078-0698-99",,Use RYDAPT,,,,
963,SM-AHN,Midostaurin,mast cell leukemia,"RYDAPT capsule, liquid filled","0078-0698-02, 0078-0698-19, 0078-0698-51, 0078-0698-99",,,,,,
964,IDH2,Enasidenib Mesylate,Acute myeloid leukemia,"IDHIFA- enasidenib mesylate tablet, film coated","59572-705-30, 59572-710-30",,,,,,
965,isocitrate dehydrogenase-2,Enasidenib Mesylate,Acute myeloid leukemia,"IDHIFA- enasidenib mesylate tablet, film coated","59572-705-30, 59572-710-30",,,,,,
966,*,Inotuzumab Ozogamicin,B-cell acute lymphoblastic leukemia,"BESPONSA- inotuzumab ozogamicin injection, powder, lyophilized, for solution",0008-0100-01,,,,,,
967,*,Tisagenlecleucel,B-cell acute lymphoblastic leukemia,"KYMRIAH- tisagenlecleucel injection, suspension","0078-0846-19, 0078-0958-19",,,,,,
968,*,Tisagenlecleucel,B-cell non-Hodgkin lymphoma,"KYMRIAH- tisagenlecleucel injection, suspension","0078-0846-19, 0078-0958-19",,,,,,
969,*,Gemtuzumab Ozogamicin,,"MYLOTARG- gemtuzumab ozogamicin injection, powder, lyophilized, for solution",0008-4510-01,,,,,,
970,*,Rituximab and Hyaluronidase Human,Follicular lymphoma,"RITUXAN HYCELA- rituximab and hyaluronidase injection, solution","50242-108-01, 50242-108-86, 50242-109-01",,,,,,
971,CHOP,Rituximab and Hyaluronidase Human,Diffuse large B-cell lymphoma,"RITUXAN HYCELA- rituximab and hyaluronidase injection, solution","50242-108-01, 50242-108-86, 50242-109-01","prednisone, cyclophosphamide, CHOP, doxorubicin, vincristine",,,,,
972,*,Rituximab and Hyaluronidase Human,Chronic lymphocytic leukemia,"RITUXAN HYCELA- rituximab and hyaluronidase injection, solution","50242-108-01, 50242-108-86, 50242-109-01","cyclophosphamide, fludarabine",,,,,
973,susceptible isocitrate dehydrogenase-1,Ivosidenib,Acute myeloid leukemia,"TIBSOVO- ivosidenib tablet, film coated",71334-100-01,,,,,,
974,isocitrate dehydrogenase-1,Ivosidenib,Acute myeloid leukemia,"TIBSOVO- ivosidenib tablet, film coated",71334-100-01,,,,,,
975,IDH1,Ivosidenib,Acute myeloid leukemia,"TIBSOVO- ivosidenib tablet, film coated",71334-100-01,,,,,,
976,*,Duvelisib,Follicular lymphoma,COPIKTRA- duvelisib capsule,"71779-115-01, 71779-115-02, 71779-115-03, 71779-125-01, 71779-125-02, 71779-125-04",,,,Yes,Yes,
977,*,Duvelisib,Chronic lymphocytic leukemia,COPIKTRA- duvelisib capsule,"71779-115-01, 71779-115-02, 71779-115-03, 71779-125-01, 71779-125-02, 71779-125-04",,,,,,
978,*,Duvelisib,small lymphocytic lymphoma,COPIKTRA- duvelisib capsule,"71779-115-01, 71779-115-02, 71779-115-03, 71779-125-01, 71779-125-02, 71779-125-04",,,,,,
979,*,Moxetumomab Pasudotox-tdfk,Hairy cell leukemia,"LUMOXITI- moxetumomab pasudotox injection, powder, lyophilized, for solution","0310-4700-01, 0310-4715-11",,,,,,
980,*,Glasdegib Maleate,Acute myeloid leukemia,"DAURISMO- glasdegib tablet, film coated","0069-0298-60, 0069-1531-30",low-dose cytarabine,,,,,
981,FLT3,Gilteritinib Fumarate,Acute myeloid leukemia,XOSPATA- gilteritinib tablet,0469-1425-90,,,,,,
982,FMS-like tyrosine kinase 3,Gilteritinib Fumarate,Acute myeloid leukemia,XOSPATA- gilteritinib tablet,0469-1425-90,,,,,,
983,blastic plasmacytoid dendritic cell,Tagraxofusp-erzs,Blastic plasmacytoid dendritic cell neoplasm,"ELZONRIS- tagraxofusp injection, solution",72187-0401-1,,,,,,
984,*,Acalabrutinib,Mantle cell lymphoma,"CALQUENCE- acalabrutinib capsule, gelatin coated","0310-0512-28, 0310-0512-60, 0310-0512-95",,,,Yes,Yes,
985,*,Acalabrutinib,Chronic lymphocytic leukemia,"CALQUENCE- acalabrutinib capsule, gelatin coated","0310-0512-28, 0310-0512-60, 0310-0512-95",,,,Yes,Yes,
986,*,Acalabrutinib,small lymphocytic lymphoma,"CALQUENCE- acalabrutinib capsule, gelatin coated","0310-0512-28, 0310-0512-60, 0310-0512-95",,,,Yes,Yes,
987,FGFR2,Pemigatinib,Cholangiocarcinoma,PEMAZYRE- pemigatinib tablet,"50881-026-01, 50881-027-01, 50881-028-01",,,,Yes,Yes,Yes
988,fibroblast growth factor receptor 2 (FGFR2) fusion,Pemigatinib,Cholangiocarcinoma,PEMAZYRE- pemigatinib tablet,"50881-026-01, 50881-027-01, 50881-028-01",,,,Yes,Yes,Yes
989,*,Pemigatinib,Cholangiocarcinoma,PEMAZYRE- pemigatinib tablet,"50881-026-01, 50881-027-01, 50881-028-01",,,,Yes,Yes,
990,*,Crizotinib,Anaplastic large cell lymphoma,XALKORI- crizotinib capsule,"0069-8140-20, 0069-8141-20",,,,,,
991,ALK,Crizotinib,Non-small cell lung cancer,XALKORI- crizotinib capsule,"0069-8140-20, 0069-8141-20",,,,,,Yes
992,anaplastic lymphoma kinase,Crizotinib,Non-small cell lung cancer,XALKORI- crizotinib capsule,"0069-8140-20, 0069-8141-20",,,,,,Yes
993,*,Erlotinib Hydrochloride,Pancreatic cancer,TARCEVA- erlotinib hydrochloride tablet,"50242-062-01, 50242-063-01, 50242-064-01",gemcitabine,,Yes,,,Yes
994,epidermal growth factor receptor (EGFR) exon 19 deletions,Erlotinib Hydrochloride,Non-small cell lung cancer,TARCEVA- erlotinib hydrochloride tablet,"50242-062-01, 50242-063-01, 50242-064-01",,,,,,Yes
995,epidermal growth factor receptor,Erlotinib Hydrochloride,Non-small cell lung cancer,TARCEVA- erlotinib hydrochloride tablet,"50242-062-01, 50242-063-01, 50242-064-01",,,,,,Yes
996,EGFR,Erlotinib Hydrochloride,Non-small cell lung cancer,TARCEVA- erlotinib hydrochloride tablet,"50242-062-01, 50242-063-01, 50242-064-01",,,,,,Yes
997,L858R,Erlotinib Hydrochloride,Non-small cell lung cancer,TARCEVA- erlotinib hydrochloride tablet,"50242-062-01, 50242-063-01, 50242-064-01",,,,,,Yes
998,EGFR mutations,Erlotinib Hydrochloride,Non-small cell lung cancer,TARCEVA- erlotinib hydrochloride tablet,"50242-062-01, 50242-063-01, 50242-064-01",,"EGFR mutations, EGFR",,,,
999,EGFR,Erlotinib Hydrochloride,Non-small cell lung cancer,TARCEVA- erlotinib hydrochloride tablet,"50242-062-01, 50242-063-01, 50242-064-01",,"EGFR mutations, EGFR",,,,
1000,•,Erlotinib Hydrochloride,Non-small cell lung cancer,TARCEVA- erlotinib hydrochloride tablet,"50242-062-01, 50242-063-01, 50242-064-01",,,,,,
1001,*,Erlotinib Hydrochloride,Non-small cell lung cancer,TARCEVA- erlotinib hydrochloride tablet,"50242-062-01, 50242-063-01, 50242-064-01",gemcitabine,,,,,
1002,epidermal growth factor receptor (EGFR) exon 19 deletions,Gefitinib,Non-small cell lung cancer,"IRESSA- gefitinib tablet, coated","0310-0482-30, 0310-0482-93",,,Yes,,,Yes
1003,epidermal growth factor receptor,Gefitinib,Non-small cell lung cancer,"IRESSA- gefitinib tablet, coated","0310-0482-30, 0310-0482-93",,,Yes,,,Yes
1004,EGFR,Gefitinib,Non-small cell lung cancer,"IRESSA- gefitinib tablet, coated","0310-0482-30, 0310-0482-93",,,Yes,,,Yes
1005,L858R,Gefitinib,Non-small cell lung cancer,"IRESSA- gefitinib tablet, coated","0310-0482-30, 0310-0482-93",,,Yes,,,Yes
1006,EGFR mutations,Gefitinib,Non-small cell lung cancer,"IRESSA- gefitinib tablet, coated","0310-0482-30, 0310-0482-93",,"EGFR mutations, EGFR, L858R",,,,
1007,EGFR,Gefitinib,Non-small cell lung cancer,"IRESSA- gefitinib tablet, coated","0310-0482-30, 0310-0482-93",,"EGFR mutations, EGFR, L858R",,,,
1008,L858R,Gefitinib,Non-small cell lung cancer,"IRESSA- gefitinib tablet, coated","0310-0482-30, 0310-0482-93",,"EGFR mutations, EGFR, L858R",,,,
1009,growth factor receptor,Afatinib Dimaleate,Non-small cell lung cancer,"GILOTRIF- afatinib tablet, film coated","0597-0137-30, 0597-0137-90, 0597-0138-30, 0597-0138-95, 0597-0141-30",,,Yes,,,Yes
1010,epidermal growth factor receptor,Afatinib Dimaleate,Non-small cell lung cancer,"GILOTRIF- afatinib tablet, film coated","0597-0137-30, 0597-0137-90, 0597-0138-30, 0597-0138-95, 0597-0141-30",,,Yes,,,Yes
1011,EGFR,Afatinib Dimaleate,Non-small cell lung cancer,"GILOTRIF- afatinib tablet, film coated","0597-0137-30, 0597-0137-90, 0597-0138-30, 0597-0138-95, 0597-0141-30",,,Yes,,,Yes
1012,EGFR mutations,Afatinib Dimaleate,Non-small cell lung cancer,"GILOTRIF- afatinib tablet, film coated","0597-0137-30, 0597-0137-90, 0597-0138-30, 0597-0138-95, 0597-0141-30",,"EGFR mutations, EGFR",,,,
1013,EGFR,Afatinib Dimaleate,Non-small cell lung cancer,"GILOTRIF- afatinib tablet, film coated","0597-0137-30, 0597-0137-90, 0597-0138-30, 0597-0138-95, 0597-0141-30",,"EGFR mutations, EGFR",,,,
1014,*,Ceritinib,Non-small cell lung cancer,ZYKADIA- ceritinib capsule,"0078-0640-70, 0078-0694-48, 0078-0694-84",,,,,,Yes
1015,L858R mutations,Osimertinib Mesylate,Non-small cell lung cancer,"TAGRISSO- osimertinib tablet, film coated","0310-1349-30, 0310-1350-30, 0310-1350-95",,,,,,
1016,epidermal growth factor receptor,Osimertinib Mesylate,Non-small cell lung cancer,"TAGRISSO- osimertinib tablet, film coated","0310-1349-30, 0310-1350-30, 0310-1350-95",,,,,,
1017,EGFR,Osimertinib Mesylate,Non-small cell lung cancer,"TAGRISSO- osimertinib tablet, film coated","0310-1349-30, 0310-1350-30, 0310-1350-95",,,,,,
1018,epidermal growth factor receptor (EGFR) exon 19 deletions,Osimertinib Mesylate,Non-small cell lung cancer,"TAGRISSO- osimertinib tablet, film coated","0310-1349-30, 0310-1350-30, 0310-1350-95",,,,,,
1019,*,Necitumumab,Squamous non-small cell lung cancer,PORTRAZZA- necitumumab solution,0002-7716-01,"cisplatin, gemcitabine",,Yes,,,Yes
1020,*,Alectinib,Non-small cell lung cancer,ALECENSA- alectinib hydrochloride capsule,"50242-130-01, 50242-130-86",,,,,,Yes
1021,BRAF V600E,Trametinib Dimethyl Sulfoxide,Non-small cell lung cancer,"MEKINIST- trametinib tablet, film coated","0078-0666-15, 0078-0668-15",dabrafenib,,,,,
1022,BRAF,Trametinib Dimethyl Sulfoxide,Non-small cell lung cancer,"MEKINIST- trametinib tablet, film coated","0078-0666-15, 0078-0668-15",dabrafenib,,,,,Yes
1023,BRAF V600E,Trametinib Dimethyl Sulfoxide,Non-small cell lung cancer,"MEKINIST- trametinib tablet, film coated","0078-0666-15, 0078-0668-15",dabrafenib,,,,,Yes
1024,BRAF,Trametinib Dimethyl Sulfoxide,Non-small cell lung cancer,"MEKINIST- trametinib tablet, film coated","0078-0666-15, 0078-0668-15",dabrafenib,,,,,
1025,BRAF V600E,Trametinib Dimethyl Sulfoxide,Melanoma,"MEKINIST- trametinib tablet, film coated","0078-0666-15, 0078-0668-15",dabrafenib,,,,,Yes
1026,BRAF V600E,Trametinib Dimethyl Sulfoxide,Melanoma,"MEKINIST- trametinib tablet, film coated","0078-0666-15, 0078-0668-15",dabrafenib,,,,,
1027,BRAF,Trametinib Dimethyl Sulfoxide,Anaplastic thyroid cancer,"MEKINIST- trametinib tablet, film coated","0078-0666-15, 0078-0668-15",dabrafenib,,,,,Yes
1028,BRAF,Dabrafenib Mesylate,Non-small cell lung cancer,TAFINLAR- dabrafenib capsule,"0078-0681-66, 0078-0682-66",,,,,,
1029,V600E,Dabrafenib Mesylate,Non-small cell lung cancer,TAFINLAR- dabrafenib capsule,"0078-0681-66, 0078-0682-66",,,,,,
1030,BRAF V600E,Dabrafenib Mesylate,Non-small cell lung cancer,TAFINLAR- dabrafenib capsule,"0078-0681-66, 0078-0682-66",trametinib,,,,,
1031,BRAF,Dabrafenib Mesylate,Non-small cell lung cancer,TAFINLAR- dabrafenib capsule,"0078-0681-66, 0078-0682-66",trametinib,,,,,Yes
1032,BRAF V600E,Dabrafenib Mesylate,Non-small cell lung cancer,TAFINLAR- dabrafenib capsule,"0078-0681-66, 0078-0682-66",trametinib,,,,,Yes
1033,BRAF,Dabrafenib Mesylate,Non-small cell lung cancer,TAFINLAR- dabrafenib capsule,"0078-0681-66, 0078-0682-66",trametinib,,,,,
1034,BRAF,Dabrafenib Mesylate,Non-small cell lung cancer,TAFINLAR- dabrafenib capsule,"0078-0681-66, 0078-0682-66",,BRAF,,,,
1035,BRAF,Dabrafenib Mesylate,Melanoma,TAFINLAR- dabrafenib capsule,"0078-0681-66, 0078-0682-66",,,,,,Yes
1036,V600E,Dabrafenib Mesylate,Melanoma,TAFINLAR- dabrafenib capsule,"0078-0681-66, 0078-0682-66",,,,,,Yes
1037,BRAF V600E,Dabrafenib Mesylate,Melanoma,TAFINLAR- dabrafenib capsule,"0078-0681-66, 0078-0682-66",trametinib,,,,,Yes
1038,BRAF V600E,Dabrafenib Mesylate,Melanoma,TAFINLAR- dabrafenib capsule,"0078-0681-66, 0078-0682-66",trametinib,,,,,
1039,BRAF,Dabrafenib Mesylate,Anaplastic thyroid cancer,TAFINLAR- dabrafenib capsule,"0078-0681-66, 0078-0682-66",trametinib,,,,,Yes
1040,*,Durvalumab,Small cell lung cancer,"IMFINZI- durvalumab injection, solution","0310-4500-12, 0310-4611-50","cisplatin, carboplatin, etoposide",,Yes,,,
1041,*,Durvalumab,Non-small cell lung cancer,"IMFINZI- durvalumab injection, solution","0310-4500-12, 0310-4611-50",,,,,,
1042,L858R substitution mutations,Dacomitinib,Non-small cell lung cancer,"VIZIMPRO- dacomitinib tablet, film coated","0069-0197-30, 0069-1198-30, 0069-2299-30",,,Yes,,,Yes
1043,epidermal growth factor receptor (EGFR) exon 19 deletion,Dacomitinib,Non-small cell lung cancer,"VIZIMPRO- dacomitinib tablet, film coated","0069-0197-30, 0069-1198-30, 0069-2299-30",,,Yes,,,Yes
1044,epidermal growth factor receptor,Dacomitinib,Non-small cell lung cancer,"VIZIMPRO- dacomitinib tablet, film coated","0069-0197-30, 0069-1198-30, 0069-2299-30",,,Yes,,,Yes
1045,EGFR,Dacomitinib,Non-small cell lung cancer,"VIZIMPRO- dacomitinib tablet, film coated","0069-0197-30, 0069-1198-30, 0069-2299-30",,,Yes,,,Yes
1046,*,Lorlatinib,Non-small cell lung cancer,"LORBRENA- lorlatinib tablet, film coated","0069-0227-01, 0069-0231-01",,,,,,Yes
1047,*,Entrectinib,Solid tumors,ROZLYTREK- entrectinib capsule,"50242-091-30, 50242-091-86, 50242-094-47, 50242-094-90",,,,Yes,Yes,
1048,neurotrophic tyrosine receptor kinase (NTRK) gene,Entrectinib,Solid tumors,ROZLYTREK- entrectinib capsule,"50242-091-30, 50242-091-86, 50242-094-47, 50242-094-90",,,,Yes,Yes,
1049,neurotrophic tyrosine receptor kinase,Entrectinib,Solid tumors,ROZLYTREK- entrectinib capsule,"50242-091-30, 50242-091-86, 50242-094-47, 50242-094-90",,,,Yes,Yes,
1050,NTRK,Entrectinib,Solid tumors,ROZLYTREK- entrectinib capsule,"50242-091-30, 50242-091-86, 50242-094-47, 50242-094-90",,,,Yes,Yes,
1051,*,Entrectinib,Non-small cell lung cancer,ROZLYTREK- entrectinib capsule,"50242-091-30, 50242-091-86, 50242-094-47, 50242-094-90",,,,Yes,Yes,Yes
1052,neurotrophic tyrosine receptor kinase (NTRK) gene,Entrectinib,Non-small cell lung cancer,ROZLYTREK- entrectinib capsule,"50242-091-30, 50242-091-86, 50242-094-47, 50242-094-90",,,,Yes,Yes,
1053,neurotrophic tyrosine receptor kinase,Entrectinib,Non-small cell lung cancer,ROZLYTREK- entrectinib capsule,"50242-091-30, 50242-091-86, 50242-094-47, 50242-094-90",,,,Yes,Yes,
1054,NTRK,Entrectinib,Non-small cell lung cancer,ROZLYTREK- entrectinib capsule,"50242-091-30, 50242-091-86, 50242-094-47, 50242-094-90",,,,Yes,Yes,
1055,*,Entrectinib,Non-small cell lung cancer,ROZLYTREK- entrectinib capsule,"50242-091-30, 50242-091-86, 50242-094-47, 50242-094-90",,,,Yes,Yes,
1056,*,Capmatinib Hydrochloride,Non-small cell lung cancer,"TABRECTA- capmatinib tablet, film coated","0078-0709-56, 0078-0709-94, 0078-0716-56, 0078-0716-94",,,,Yes,Yes,Yes
1057,*,Capmatinib Hydrochloride,Non-small cell lung cancer,"TABRECTA- capmatinib tablet, film coated","0078-0709-56, 0078-0709-94, 0078-0716-56, 0078-0716-94",,,,Yes,Yes,
1058,*,Selpercatinib,Thyroid cancer,RETEVMO- selpercatinib capsule,"0002-2980-26, 0002-2980-60, 0002-3977-60",,,,Yes,Yes,
1059,*,Selpercatinib,Medullary thyroid cancer,RETEVMO- selpercatinib capsule,"0002-2980-26, 0002-2980-60, 0002-3977-60",,,,Yes,Yes,
1060,*,Selpercatinib,Non-small cell lung cancer,RETEVMO- selpercatinib capsule,"0002-2980-26, 0002-2980-60, 0002-3977-60",,,,Yes,Yes,
1061,RET,Pralsetinib,Thyroid cancer,GAVRETO- pralsetinib capsule,"72064-210-12, 72064-210-60, 72064-210-90",,,,Yes,Yes,
1062,*,Pralsetinib,Thyroid cancer,GAVRETO- pralsetinib capsule,"72064-210-12, 72064-210-60, 72064-210-90",,,,Yes,Yes,
1063,RET,Pralsetinib,Medullary thyroid cancer,GAVRETO- pralsetinib capsule,"72064-210-12, 72064-210-60, 72064-210-90",,,,Yes,Yes,
1064,*,Pralsetinib,Medullary thyroid cancer,GAVRETO- pralsetinib capsule,"72064-210-12, 72064-210-60, 72064-210-90",,,,Yes,Yes,
1065,RET,Pralsetinib,Non-small cell lung cancer,GAVRETO- pralsetinib capsule,"72064-210-12, 72064-210-60, 72064-210-90",,,,Yes,Yes,
1066,*,Pralsetinib,Non-small cell lung cancer,GAVRETO- pralsetinib capsule,"72064-210-12, 72064-210-60, 72064-210-90",,,,Yes,Yes,
1067,laCSCC,Cemiplimab-rwlc,Cutaneous squamous cell carcinoma,LIBTAYO- cemiplimab-rwlc injection,61755-008-01,,,,,,Yes
1068,mCSCC,Cemiplimab-rwlc,Cutaneous squamous cell carcinoma,LIBTAYO- cemiplimab-rwlc injection,61755-008-01,,,,,,Yes
1069,*,Cemiplimab-rwlc,Basal cell carcinoma,LIBTAYO- cemiplimab-rwlc injection,61755-008-01,,,,Yes,Yes,
1070,mBCC,Cemiplimab-rwlc,Basal cell carcinoma,LIBTAYO- cemiplimab-rwlc injection,61755-008-01,,,,Yes,Yes,
1071,PD-L1,Cemiplimab-rwlc,Non-small cell lung cancer,LIBTAYO- cemiplimab-rwlc injection,61755-008-01,,"ROS1, EGFR, ALK",Yes,,,
1072,ROS1,Cemiplimab-rwlc,Non-small cell lung cancer,LIBTAYO- cemiplimab-rwlc injection,61755-008-01,,"ROS1, EGFR, ALK",Yes,,,
1073,EGFR,Cemiplimab-rwlc,Non-small cell lung cancer,LIBTAYO- cemiplimab-rwlc injection,61755-008-01,,"ROS1, EGFR, ALK",Yes,,,
1074,ALK,Cemiplimab-rwlc,Non-small cell lung cancer,LIBTAYO- cemiplimab-rwlc injection,61755-008-01,,"ROS1, EGFR, ALK",Yes,,,
1075,*,Tepotinib Hydrochloride,Non-small cell lung cancer,TEPMETKO- tepotinib hydrochloride tablet,"44087-5000-3, 44087-5000-6",,,,Yes,Yes,Yes
1076,*,Tepotinib Hydrochloride,Non-small cell lung cancer,TEPMETKO- tepotinib hydrochloride tablet,"44087-5000-3, 44087-5000-6",,,,Yes,Yes,
1077,*,Ibritumomab Tiuxetan,B-cell  follicular non-Hodgkin lymphoma,,,,,,,,
1078,*,Brentuximab Vedotin,Peripheral T-cell lymphoma,"ADCETRIS- brentuximab vedotin injection, powder, lyophilized, for solution",51144-050-01,"cyclophosphamide, doxorubicin, prednisone",,,,,
1079,CD30-expressing MF,Brentuximab Vedotin,Cutaneous anaplastic large cell lymphoma,"ADCETRIS- brentuximab vedotin injection, powder, lyophilized, for solution",51144-050-01,,,,,,
1080,*,Brentuximab Vedotin,Anaplastic large cell lymphoma,"ADCETRIS- brentuximab vedotin injection, powder, lyophilized, for solution",51144-050-01,"cyclophosphamide, doxorubicin, prednisone",,,,,
1081,*,Brentuximab Vedotin,Anaplastic large cell lymphoma,"ADCETRIS- brentuximab vedotin injection, powder, lyophilized, for solution",51144-050-01,,,,,,
1082,CD30-expressing MF,Brentuximab Vedotin,Anaplastic large cell lymphoma,"ADCETRIS- brentuximab vedotin injection, powder, lyophilized, for solution",51144-050-01,,,,,,
1083,*,Brentuximab Vedotin,Hodgkinlymphoma.,"ADCETRIS- brentuximab vedotin injection, powder, lyophilized, for solution",51144-050-01,,,,,,
1084,CD30-expressing MF,Brentuximab Vedotin,Mycosis fungoides,"ADCETRIS- brentuximab vedotin injection, powder, lyophilized, for solution",51144-050-01,,,,,,
1085,*,Romidepsin,Cutaneous T-cell lymphoma,,,,,,,,
1086,*,Romidepsin,Peripheral T-cell lymphoma,,,,,,,,
1087,*,Bexarotene,Skin problems caused by cutaneous T-cell lymphoma,BEXAROTENE capsule,69238-1250-1,,,,,,
1088,*,Bexarotene,Skin problems caused by cutaneous T-cell lymphoma,"BEXAROTENE capsule, liquid filled",43975-315-10,,,,,,
1089,*,Bexarotene,Skin problems caused by cutaneous T-cell lymphoma,"BEXAROTENE capsule, liquid filled",0054-0399-25,,,,,,
1090,*,Bexarotene,Skin problems caused by cutaneous T-cell lymphoma,"BEXAROTENE capsule, liquid filled",0378-6955-01,,,,,,
1091,*,Bexarotene,Skin problems caused by cutaneous T-cell lymphoma,"BEXAROTENE capsule, liquid filled",68682-003-10,,,,,,
1092,*,Bexarotene,Skin problems caused by cutaneous T-cell lymphoma,BEXAROTENE capsule,0832-0285-00,,,,,,
1093,*,Bexarotene,Skin problems caused by cutaneous T-cell lymphoma,targretin- bexarotene gel,64365-504-01,,,,,,
1094,*,Bexarotene,Skin problems caused by cutaneous T-cell lymphoma,"TARGRETIN- bexarotene capsule, liquid filled",0187-5526-75,,,,,,
1095,*,Bexarotene,Skin problems caused by cutaneous T-cell lymphoma,TARGRETIN- bexarotene gel,0187-5525-60,,,,,,
1096,Bortezomib,Bortezomib,Mantle cell lymphoma,"BORTEZOMIB- bortexomib injection, powder, lyophilized, for solution",43598-865-60,,,,,,
1097,Bortezomib,Bortezomib,Multiple myeloma,"BORTEZOMIB- bortexomib injection, powder, lyophilized, for solution",43598-865-60,,,,,,
1098,*,Bortezomib,Mantle cell lymphoma,"BORTEZOMIB injection, powder, lyophilized, for solution",63323-721-10,,,,,,
1099,*,Bortezomib,Multiple myeloma,"BORTEZOMIB injection, powder, lyophilized, for solution",63323-721-10,,,,,,
1100,*,Bortezomib,Mantle cell lymphoma,"VELCADE- bortezomib injection, powder, lyophilized, for solution",63020-049-01,,,,,,
1101,*,Bortezomib,Multiple myeloma,"VELCADE- bortezomib injection, powder, lyophilized, for solution",63020-049-01,,,,,,
1102,*,Pralatrexate,Peripheral T-cell lymphoma,FOLOTYN- pralatrexate injection,"48818-001-01, 48818-001-02",,,,,,
1103,*,Siltuximab,Multicentric Castleman disease,,,,,,,,
1104,*,Belinostat,Peripheral T-cell lymphoma,,,,,,,,
1105,*,Copanlisib Hydrochloride,Follicular lymphoma,"ALIQOPA- copanlisib injection, powder, lyophilized, for solution","50419-385-01, 50419-385-72",,,,Yes,Yes,
1106,*,Axicabtagene Ciloleucel,B-cell non-Hodgkin lymphoma,YESCARTA- axicabtagene ciloleucel suspension,"71287-119-01, 71287-119-02",,,,,,
1107,*,Mogamulizumab-kpkc,Sezary syndrome,POTELIGEO- mogamulizumab-kpkc injection,42747-761-01,,,,,,
1108,*,Mogamulizumab-kpkc,Mycosis fungoides,POTELIGEO- mogamulizumab-kpkc injection,42747-761-01,,,,,,
1109,rituximab product,Polatuzumab Vedotin-piiq,Diffuse large B-cell lymphoma,"POLIVY- polatuzumab vedotin injection, powder, lyophilized, for solution","50242-103-01, 50242-105-01","bendamustine, rituximab",,,Yes,Yes,
1110,*,Polatuzumab Vedotin-piiq,Diffuse large B-cell lymphoma,"POLIVY- polatuzumab vedotin injection, powder, lyophilized, for solution","50242-103-01, 50242-105-01",,,,Yes,Yes,
1111,*,Zanubrutinib,Mantle cell lymphoma,"BRUKINSA- zanubrutinib capsule, gelatin coated","72579-011-01, 72579-011-02",,,,Yes,Yes,
1112,EZH2,Tazemetostat Hydrobromide,Follicular lymphoma,"TAZVERIK- tazemetostat tablet, film coated",72607-100-00,,,,Yes,Yes,
1113,EZH2 mutation,Tazemetostat Hydrobromide,Follicular lymphoma,"TAZVERIK- tazemetostat tablet, film coated",72607-100-00,,,,Yes,Yes,
1114,*,Tazemetostat Hydrobromide,Follicular lymphoma,"TAZVERIK- tazemetostat tablet, film coated",72607-100-00,,,,Yes,Yes,
1115,*,Tazemetostat Hydrobromide,Epithelioid sarcoma,"TAZVERIK- tazemetostat tablet, film coated",72607-100-00,,,,Yes,Yes,
1116,*,Selinexor,Diffuse large B-cell lymphoma,"XPOVIO- selinexor tablet, film coated","72237-101-01, 72237-101-02, 72237-101-03, 72237-101-04, 72237-101-05, 72237-101-06, 72237-101-07, 72237-101-11, 72237-101-12, 72237-101-13, 72237-101-14, 72237-101-15, 72237-101-16, 72237-101-17, 72237-102-02, 72237-102-06, 72237-102-07, 72237-102-12, 72237-102-16, 72237-102-17, 72237-103-05, 72237-103-15, 72237-104-01, 72237-104-11","dexamethasone, bortezomib",,,Yes,Yes,
1117,anti-CD38 monoclonal antibody,Selinexor,Diffuse large B-cell lymphoma,"XPOVIO- selinexor tablet, film coated","72237-101-01, 72237-101-02, 72237-101-03, 72237-101-04, 72237-101-05, 72237-101-06, 72237-101-07, 72237-101-11, 72237-101-12, 72237-101-13, 72237-101-14, 72237-101-15, 72237-101-16, 72237-101-17, 72237-102-02, 72237-102-06, 72237-102-07, 72237-102-12, 72237-102-16, 72237-102-17, 72237-103-05, 72237-103-15, 72237-104-01, 72237-104-11",dexamethasone,,,Yes,Yes,
1118,*,Selinexor,Diffuse large B-cell lymphoma,"XPOVIO- selinexor tablet, film coated","72237-101-01, 72237-101-02, 72237-101-03, 72237-101-04, 72237-101-05, 72237-101-06, 72237-101-07, 72237-101-11, 72237-101-12, 72237-101-13, 72237-101-14, 72237-101-15, 72237-101-16, 72237-101-17, 72237-102-02, 72237-102-06, 72237-102-07, 72237-102-12, 72237-102-16, 72237-102-17, 72237-103-05, 72237-103-15, 72237-104-01, 72237-104-11",,,,Yes,Yes,
1119,*,Selinexor,Multiple myeloma,"XPOVIO- selinexor tablet, film coated","72237-101-01, 72237-101-02, 72237-101-03, 72237-101-04, 72237-101-05, 72237-101-06, 72237-101-07, 72237-101-11, 72237-101-12, 72237-101-13, 72237-101-14, 72237-101-15, 72237-101-16, 72237-101-17, 72237-102-02, 72237-102-06, 72237-102-07, 72237-102-12, 72237-102-16, 72237-102-17, 72237-103-05, 72237-103-15, 72237-104-01, 72237-104-11","dexamethasone, bortezomib",,,,,
1120,anti-CD38 monoclonal antibody,Selinexor,Multiple myeloma,"XPOVIO- selinexor tablet, film coated","72237-101-01, 72237-101-02, 72237-101-03, 72237-101-04, 72237-101-05, 72237-101-06, 72237-101-07, 72237-101-11, 72237-101-12, 72237-101-13, 72237-101-14, 72237-101-15, 72237-101-16, 72237-101-17, 72237-102-02, 72237-102-06, 72237-102-07, 72237-102-12, 72237-102-16, 72237-102-17, 72237-103-05, 72237-103-15, 72237-104-01, 72237-104-11",dexamethasone,,,,,
1121,*,Tafasitamab-cxix,Diffuse large B-cell lymphoma,"MONJUVI- tafasitamab-cxix injection, powder, lyophilized, for solution",73535-208-01,lenalidomide,,,Yes,Yes,
1122,*,Tafasitamab-cxix,Diffuse large B-cell lymphoma,"MONJUVI- tafasitamab-cxix injection, powder, lyophilized, for solution",73535-208-01,,,,Yes,Yes,
1123,*,Brexucabtagene Autoleucel,Mantle cell lymphoma,TECARTUS- brexucabtagene autoleucel suspension,"71287-219-01, 71287-219-02",,,,Yes,Yes,
1124,*,Umbralisib Tosylate,Follicular lymphoma,"UKONIQ- umbralisib tablet, film coated",73150-200-12,,,,Yes,Yes,
1125,*,Umbralisib Tosylate,Marginal zone lymphoma,"UKONIQ- umbralisib tablet, film coated",73150-200-12,,,,Yes,Yes,
1126,*,Loncastuximab Tesirine-lpyl,B-cell non-Hodgkin lymphoma,"ZYNLONTA- loncastuximab tesirine injection, powder, lyophilized, for solution",79952-110-01,,,,,,
1127,*,Carfilzomib,Multiple myeloma,"KYPROLIS- carfilzomib injection, powder, lyophilized, for solution","76075-101-01, 76075-102-01, 76075-103-01","Daratumumab, dexamethasone, Lenalidomide, Dexamethasone",,,,,
1128,*,Carfilzomib,Multiple myeloma,"KYPROLIS- carfilzomib injection, powder, lyophilized, for solution","76075-101-01, 76075-102-01, 76075-103-01",,,,,,
1129,histone deacetylase,Panobinostat Lactate,Multiple myeloma,FARYDAK- panobinostat capsule,"0078-0650-06, 0078-0651-06, 0078-0652-06","dexamethasone, bortezomib",,,Yes,,
1130,bortezomib,Panobinostat Lactate,Multiple myeloma,FARYDAK- panobinostat capsule,"0078-0650-06, 0078-0651-06, 0078-0652-06","dexamethasone, bortezomib",,,Yes,,
1131,*,Panobinostat Lactate,Multiple myeloma,FARYDAK- panobinostat capsule,"0078-0650-06, 0078-0651-06, 0078-0652-06",,,,Yes,,
1132,*,Daratumumab,Multiple myeloma,"DARZALEX- daratumumab injection, solution, concentrate","57894-502-05, 57894-502-20","dexamethasone, lenalidomide",,,,,
1133,*,Daratumumab,Multiple myeloma,"DARZALEX- daratumumab injection, solution, concentrate","57894-502-05, 57894-502-20","melphalan, bortezomib, prednisone",,,,,
1134,bortezomib,Daratumumab,Multiple myeloma,"DARZALEX- daratumumab injection, solution, concentrate","57894-502-05, 57894-502-20","thalidomide, dexamethasone, bortezomib",,,,,
1135,*,Daratumumab,Multiple myeloma,"DARZALEX- daratumumab injection, solution, concentrate","57894-502-05, 57894-502-20","dexamethasone, carfilzomib",,,,,
1136,*,Daratumumab,Multiple myeloma,"DARZALEX- daratumumab injection, solution, concentrate","57894-502-05, 57894-502-20","dexamethasone, pomalidomide, lenalidomide",,,,,
1137,PI,Daratumumab,Multiple myeloma,"DARZALEX- daratumumab injection, solution, concentrate","57894-502-05, 57894-502-20",,,,,,
1138,double-refractory,Daratumumab,Multiple myeloma,"DARZALEX- daratumumab injection, solution, concentrate","57894-502-05, 57894-502-20",,,,,,
1139,proteasome inhibitor,Daratumumab,Multiple myeloma,"DARZALEX- daratumumab injection, solution, concentrate","57894-502-05, 57894-502-20",,,,,,
1140,*,Ixazomib Citrate,Multiple myeloma,NINLARO- ixazomib capsule,"63020-078-01, 63020-078-02, 63020-079-01, 63020-079-02, 63020-080-01, 63020-080-02","dexamethasone, lenalidomide",,,,,
1141,*,Elotuzumab,Multiple myeloma,"EMPLICITI- elotuzumab injection, powder, lyophilized, for solution","0003-2291-11, 0003-4522-11","dexamethasone, lenalidomide",,,,,
1142,*,Elotuzumab,Multiple myeloma,"EMPLICITI- elotuzumab injection, powder, lyophilized, for solution","0003-2291-11, 0003-4522-11","dexamethasone, pomalidomide, lenalidomide",,,,,
1143,*,Isatuximab-irfc,Multiple myeloma,"SARCLISA- isatuximab injection, solution, concentrate","0024-0654-01, 0024-0656-01","dexamethasone, pomalidomide, lenalidomide",,,,,
1144,*,Isatuximab-irfc,Multiple myeloma,"SARCLISA- isatuximab injection, solution, concentrate","0024-0654-01, 0024-0656-01","dexamethasone, carfilzomib",,,,,
1145,*,Daratumumab and Hyaluronidase-fihj,Light-chain amyloidosis,DARZALEX FASPRO (daratumumab and hyaluronidase-fihj- human recombinant injection,57894-503-01,,,,,,
1146,DARZALEX,Daratumumab and Hyaluronidase-fihj,Multiple myeloma,DARZALEX FASPRO (daratumumab and hyaluronidase-fihj- human recombinant injection,57894-503-01,"melphalan, bortezomib, prednisone",,,,,
1147,bortezomib,Daratumumab and Hyaluronidase-fihj,Multiple myeloma,DARZALEX FASPRO (daratumumab and hyaluronidase-fihj- human recombinant injection,57894-503-01,"melphalan, bortezomib, prednisone",,,,,
1148,*,Daratumumab and Hyaluronidase-fihj,Multiple myeloma,DARZALEX FASPRO (daratumumab and hyaluronidase-fihj- human recombinant injection,57894-503-01,"dexamethasone, lenalidomide",,,,,
1149,*,Daratumumab and Hyaluronidase-fihj,Multiple myeloma,DARZALEX FASPRO (daratumumab and hyaluronidase-fihj- human recombinant injection,57894-503-01,"thalidomide, dexamethasone, bortezomib",,,,,
1150,*,Daratumumab and Hyaluronidase-fihj,Multiple myeloma,DARZALEX FASPRO (daratumumab and hyaluronidase-fihj- human recombinant injection,57894-503-01,"dexamethasone, bortezomib",,,,,
1151,PI,Daratumumab and Hyaluronidase-fihj,Multiple myeloma,DARZALEX FASPRO (daratumumab and hyaluronidase-fihj- human recombinant injection,57894-503-01,,,,,,
1152,double-refractory,Daratumumab and Hyaluronidase-fihj,Multiple myeloma,DARZALEX FASPRO (daratumumab and hyaluronidase-fihj- human recombinant injection,57894-503-01,,,,,,
1153,proteasome inhibitor,Daratumumab and Hyaluronidase-fihj,Multiple myeloma,DARZALEX FASPRO (daratumumab and hyaluronidase-fihj- human recombinant injection,57894-503-01,,,,,,
1154,anti-CD38 monoclonal antibody,Belantamab Mafodotin-blmf,Multiple myeloma,"BLENREP- belantamab injection, powder, lyophilized, for solution",0173-0896-01,,,,Yes,Yes,
1155,proteasome,Belantamab Mafodotin-blmf,Multiple myeloma,"BLENREP- belantamab injection, powder, lyophilized, for solution",0173-0896-01,,,,Yes,Yes,
1156,*,Belantamab Mafodotin-blmf,Multiple myeloma,"BLENREP- belantamab injection, powder, lyophilized, for solution",0173-0896-01,,,,Yes,Yes,
1157,proteasome,Melphalan Flufenamide Hydrochloride,Multiple myeloma,"PEPAXTO- melphalan flufenamide injection, powder, lyophilized, for solution",73657-020-01,dexamethasone,,,Yes,Yes,
1158,CD38-directed monoclonal antibody,Melphalan Flufenamide Hydrochloride,Multiple myeloma,"PEPAXTO- melphalan flufenamide injection, powder, lyophilized, for solution",73657-020-01,dexamethasone,,,Yes,Yes,
1159,*,Melphalan Flufenamide Hydrochloride,Multiple myeloma,"PEPAXTO- melphalan flufenamide injection, powder, lyophilized, for solution",73657-020-01,,,,Yes,Yes,
1160,anti-CD38 monoclonal antibody,Idecabtagene Vicleucel,Multiple myeloma,ABECMA- idecabtagene vicleucel suspension,"59572-515-01, 59572-515-02, 59572-515-03",,,,,,
1161,B-cell maturation antigen,Idecabtagene Vicleucel,Multiple myeloma,ABECMA- idecabtagene vicleucel suspension,"59572-515-01, 59572-515-02, 59572-515-03",,,,,,
1162,proteasome,Idecabtagene Vicleucel,Multiple myeloma,ABECMA- idecabtagene vicleucel suspension,"59572-515-01, 59572-515-02, 59572-515-03",,,,,,
1163,PV,Ruxolitinib Phosphate,Polycythemia vera,JAKAFI- ruxolitinib tablet,"50881-005-60, 50881-010-01, 50881-010-60, 50881-015-60, 50881-020-60, 50881-025-60",,,,,,
1164,*,Ruxolitinib Phosphate,Myelofibrosis,JAKAFI- ruxolitinib tablet,"50881-005-60, 50881-010-01, 50881-010-60, 50881-015-60, 50881-020-60, 50881-025-60",,,,,,
1165,*,Fedratinib Hydrochloride,Myelofibrosis,INREBIC- fedratinib hydrochloride capsule,59572-720-12,,,,,,
1166,13-cis-retinoic acid,Dinutuximab,Neuroblastoma,UNITUXIN- dinutuximab injection,66302-014-01,13-cis-retinoic acid,,,,,
1167,IL-2,Dinutuximab,Neuroblastoma,UNITUXIN- dinutuximab injection,66302-014-01,13-cis-retinoic acid,,,,,
1168,GM-CSF,Dinutuximab,Neuroblastoma,UNITUXIN- dinutuximab injection,66302-014-01,13-cis-retinoic acid,,,,,
1169,interleukin-2,Dinutuximab,Neuroblastoma,UNITUXIN- dinutuximab injection,66302-014-01,13-cis-retinoic acid,,,,,
1170,granulocyte-macrophage colony-stimulating factor,Dinutuximab,Neuroblastoma,UNITUXIN- dinutuximab injection,66302-014-01,13-cis-retinoic acid,,,,,
1171,granulocyte-macrophage colony-stimulating factor,Naxitamab-gqgk,Neuroblastoma,DANYELZA- naxitamab injection,73042-201-01,,,,Yes,Yes,
1172,GM-CSF,Naxitamab-gqgk,Neuroblastoma,DANYELZA- naxitamab injection,73042-201-01,,,,Yes,Yes,
1173,*,Naxitamab-gqgk,Neuroblastoma,DANYELZA- naxitamab injection,73042-201-01,,,,Yes,Yes,
1174,Rubraca,Rucaparib Camsylate,fallopian tube,"RUBRACA- rucaparib tablet, film coated","69660-201-91, 69660-202-91, 69660-203-91",,,,Yes,Yes,
1175,BRCA mutation,Rucaparib Camsylate,fallopian tube,"RUBRACA- rucaparib tablet, film coated","69660-201-91, 69660-202-91, 69660-203-91",,,,Yes,Yes,
1176,androgen,Rucaparib Camsylate,fallopian tube,"RUBRACA- rucaparib tablet, film coated","69660-201-91, 69660-202-91, 69660-203-91",,,,Yes,Yes,
1177,BRCA Mutations,Rucaparib Camsylate,fallopian tube,"RUBRACA- rucaparib tablet, film coated","69660-201-91, 69660-202-91, 69660-203-91",,,,Yes,Yes,
1178,*,Rucaparib Camsylate,fallopian tube,"RUBRACA- rucaparib tablet, film coated","69660-201-91, 69660-202-91, 69660-203-91",,,,Yes,Yes,
1179,Rubraca,Rucaparib Camsylate,primary peritoneal cancer,"RUBRACA- rucaparib tablet, film coated","69660-201-91, 69660-202-91, 69660-203-91",,,,Yes,Yes,
1180,BRCA mutation,Rucaparib Camsylate,primary peritoneal cancer,"RUBRACA- rucaparib tablet, film coated","69660-201-91, 69660-202-91, 69660-203-91",,,,Yes,Yes,
1181,androgen,Rucaparib Camsylate,primary peritoneal cancer,"RUBRACA- rucaparib tablet, film coated","69660-201-91, 69660-202-91, 69660-203-91",,,,Yes,Yes,
1182,BRCA Mutations,Rucaparib Camsylate,primary peritoneal cancer,"RUBRACA- rucaparib tablet, film coated","69660-201-91, 69660-202-91, 69660-203-91",,,,Yes,Yes,
1183,*,Rucaparib Camsylate,primary peritoneal cancer,"RUBRACA- rucaparib tablet, film coated","69660-201-91, 69660-202-91, 69660-203-91",,,,Yes,Yes,
1184,Rubraca,Rucaparib Camsylate,Prostate cancer,"RUBRACA- rucaparib tablet, film coated","69660-201-91, 69660-202-91, 69660-203-91",,,,Yes,Yes,
1185,BRCA mutation,Rucaparib Camsylate,Prostate cancer,"RUBRACA- rucaparib tablet, film coated","69660-201-91, 69660-202-91, 69660-203-91",,,,Yes,Yes,
1186,androgen,Rucaparib Camsylate,Prostate cancer,"RUBRACA- rucaparib tablet, film coated","69660-201-91, 69660-202-91, 69660-203-91",,,,Yes,Yes,
1187,BRCA Mutations,Rucaparib Camsylate,Prostate cancer,"RUBRACA- rucaparib tablet, film coated","69660-201-91, 69660-202-91, 69660-203-91",,,,Yes,Yes,
1188,*,Rucaparib Camsylate,Prostate cancer,"RUBRACA- rucaparib tablet, film coated","69660-201-91, 69660-202-91, 69660-203-91",,,,Yes,Yes,
1189,*,Rucaparib Camsylate,Ovarian epithelial,"RUBRACA- rucaparib tablet, film coated","69660-201-91, 69660-202-91, 69660-203-91",,,,,,
1190,*,Niraparib Tosylate Monohydrate,fallopian tube,,,,,,,,
1191,*,Niraparib Tosylate Monohydrate,primary peritoneal cancer,,,,,,,,
1192,*,Niraparib Tosylate Monohydrate,Ovarian epithelial,,,,,,,,
1193,NF1,Selumetinib Sulfate,Neurofibromatosis type 1,KOSELUGO- selumetinib capsule,"0310-0610-28, 0310-0610-60, 0310-0625-28, 0310-0625-60",,,,,,
1194,neurofibromatosis type 1,Selumetinib Sulfate,Neurofibromatosis type 1,KOSELUGO- selumetinib capsule,"0310-0610-28, 0310-0610-60, 0310-0625-28, 0310-0625-60",,,,,,
1195,*,Cabazitaxel,Prostate cancer,JEVTANA- cabazitaxel kit,"0024-5822-01, 0024-5823-15, 0024-5824-11",prednisone,,,,,
1196,*,Enzalutamide,Prostate cancer,XTANDI- enzalutamide capsule,0469-0125-99,,,,,,
1197,*,Abiraterone Acetate,Prostate cancer,ZYTIGA- abiraterone acetate tablet,"57894-150-12, 57894-150-25, 57894-195-06, 57894-195-15",prednisone,,,,,
1198,*,Radium 223 Dichloride,Prostate cancer,XOFIGO- radium ra 223 dichloride injection,50419-208-01,,,,,,
1199,*,Apalutamide,Prostatecancer.,"ERLEADA- apalutamide tablet, film coated","59676-600-12, 59676-600-56, 59676-600-99",,,,,,
1200,*,Darolutamide,Prostate cancer,"NUBEQA- darolutamide tablet, film coated","50419-395-01, 50419-395-72",,,,,,
1201,*,Vismodegib,Basal cell carcinoma,ERIVEDGE- vismodegib capsule,"50242-140-01, 50242-140-86",,,,,,Yes
1202,*,Sonidegib,Basal cell carcinoma,ODOMZO- sonidegib capsule,47335-303-83,,,,,,
1203,BRAF,Vemurafenib,Erdheim-Chester disease,"ZELBORAF- vemurafenib tablet, film coated","50242-090-01, 50242-090-02, 50242-090-86",,,,,,
1204,ECD,Vemurafenib,Erdheim-Chester disease,"ZELBORAF- vemurafenib tablet, film coated","50242-090-01, 50242-090-02, 50242-090-86",,,,,,
1205,BRAF,Vemurafenib,Melanoma,"ZELBORAF- vemurafenib tablet, film coated","50242-090-01, 50242-090-02, 50242-090-86",,,,,,Yes
1206,BRAF,Vemurafenib,Melanoma,"ZELBORAF- vemurafenib tablet, film coated","50242-090-01, 50242-090-02, 50242-090-86",,BRAF,,,,
1207,BRAF V600E,Cobimetinib Fumarate,Melanoma,"COTELLIC- cobimetinib tablet, film coated","50242-717-01, 50242-717-86",vemurafenib,,,,,Yes
1208,vemurafenib,Cobimetinib Fumarate,Melanoma,"COTELLIC- cobimetinib tablet, film coated","50242-717-01, 50242-717-86",vemurafenib,,,,,Yes
1209,BRAF V600E,Binimetinib,Melanoma,"MEKTOVI- binimetinib tablet, film coated","70255-010-02, 70255-010-03",encorafenib,,,,,Yes
